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ABSTRACT
Fragile X Syndrome (FXS) is a neurodevelopmental disorder caused by the
disruption of Fragile X Mental Retardation Protein (FMRP) function in neurons, affecting
nearly 1 in 7,500 individuals. Although FXS typically occurs from a complete loss of
FMRP expression due to a CGG trinucleotide expansion within the 5’UTR of the FMR1
gene, single nucleotide polymorphisms (SNPs) within the KH domains of FMRP have been
shown to severely disrupt FMRP function. FMRP is an RNA-binding translation repressor
that interacts with ~4% of the neuronal transcriptome. Many target mRNAs encode for
proteins important for regulating synaptic processes and modulate synaptic plasticity. It is
likely that FMRP differentially regulates this large subset of mRNAs via its association
with specific membraneless organelles (MLOs), or granules, that are each involved in
regulating different processes of the transcript lifecycle. How FMRP forms and interacts
with different MLOs however, is largely unknown. Here we show that multivalent
interactions via the two canonical KH domains, KH1 and KH2, and the C-terminal
intrinsically disordered region (IDR) function cooperatively to promote FMRP granule
formation in Drosophila S2 cells.
Two mutations within the KH domains of FMRP have been linked to severe forms
of FXS. We were interested in determining whether these mutations disrupted the
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formation or function of FMRP-containing MLOs. Here we studied these missense point
mutations, by making the orthologous mutations in the fly KH1 (Gly269Glu) and KH2
(Ile307Asn) domains. Within FRAP experiments of fly S2 cells we found that each of the
KH point mutants destabilized the dynamic mobile fraction of FMRP granules, while
having no impact on immobile fractions. The KH1 mutant in particular has an important
function in granule formation and FMRP association with other MLOs involved in posttranscriptional regulation including stress granules and RNA Processing-bodies.
Additionally, we found that the KH1 mutation is defective in FMRP-mediated translation,
while the KH2 mutant has no effect.
We also studied the impact of these mutations in Drosophila primary motor neurons
(MNs) where FMRP associates with neuronal RNA transport granules (NGs). Within NGs
FMRP is thought to translationally repress transcripts during their active transport from the
soma out to the synapse. Interestingly, we found that the KH1 mutant severely disrupted
the nucleation of FMRP-positive NGs. The KH2 mutant on the other hand destabilized
NGs, impacting NG transport out in neurites. Interestingly, we found that these mutations
had no impact on camkii transport, a well characterized FMRP target, suggesting that
FMRP-NG association and RNA transport may not be functionally linked processes.
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CHAPTER ONE: BACKGROUND AND SIGNIFICANCE
1.1 Fragile X Syndrome
1.1.1 Disease occurrence and phenotypes
Fragile X Syndrome (FXS) is the most common monogenic cause of inherited
mental and intellectual disability, affecting roughly 1 in 5,000 males and 1 in 10,000
females (Coffee et al., 2009). This developmental disorder can present various symptoms
in those affected ranging from mild to severe. This includes developmental delays in
walking and talking, as well as difficulty learning new tasks (Garber et al., 2008). Social
and behavioral problems such as difficulty making eye contact, attention deficits, hand
flapping, hyperactivity, and anxiety are also common in affected individuals. Additionally,
seizures occur in roughly 15% of affected males and 5% of affected females (Garber et al.,
2008). Physical symptoms typically manifest in individuals with FXS following puberty
which include distinct facial features such as an enlarged head and ears with a long narrow
face, prominent jaw and forehead, unusually flexible joints, flat feet, and in males,
macroorchidism (Neri, 2017). FXS also has a high comorbidity with autism spectrum
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disorders (ASD), which occurs in roughly 1 out of 3 individuals with FXS (Abbeduto et
al., 2014).
1.1.2 Neuronal defects of FXS
FXS is caused by the disruption of the fragile X mental retardation 1 (FMR1) gene
which encodes the Fragile X Mental Retardation Protein (FMRP). FMRP is expressed
throughout the body, but is enriched in the testes, ovaries and throughout the brain (Christie
et al., 2009). FMRP is an RNA-binding protein (RBP) that interacts with roughly 4% of
neuronal transcripts, many of which encode for proteins required for synaptic plasticity
(Ashley et al., 1993; Brown et al., 2001; Sidorov et al., 2013).
Synaptic plasticity is the dynamic ability of neurons to strengthen or weaken
connections with other neurons in an activity-dependent manner over time. Activitydependent alterations in synaptic strength include: 1) retaining and strengthening synapses
commonly referred to as long-term potentiation (LTP) and 2) synapse weakening and
elimination referred to as long-term depression (LTD) (Magee and Grienberger, 2020).
This orchestration of strengthening and pruning synapses in response to activity is thought
to be the mechanism underlying learning and memory formation (Nabavi et al., 2014).
Neurons are capable of regulating synaptic strength cell-wide in response to drastic
changes in network activity in a process called synaptic scaling (Turrigiano, 2008). On the
molecular level, this process is carried out via the regulation of receptor trafficking out to
the synapse (e.g. increased network activity will stimulate the neuron to scale down
synaptic strength by reducing receptor trafficking out to synaptic sites). FMRP particularly
2

affects new protein synthesis-dependent mechanisms of synaptic plasticity and synaptic
scaling. Loss of synaptic scaling up in FMR1 KO neurons was able to be rescued with the
reintroduction of FMRP in the postsynaptic neuron (Soden and Chen, 2010).
A major phenotype observed in FXS is an overelaboration of immature dendritic
spines due to aberrant activity-independent translation at synapses (Scotto-Lomassese et
al., 2011). Loss of FMRP causes an increased density, or overgrowth, of dendritic and
axonal protrusions which is thought to result from a loss of regulation of some cytoskeletal
targets of FMRP, such as the microtubule associated protein, futsch (Zhang et al., 2001).
The mGluR theory of FXS (Figure 1) posits that FMRP modulates synaptic
plasticity by regulating protein synthesis of postsynaptic transcripts required to maintain
LTD triggered by group 1 and 5 metabotropic glutamate receptor (mGluR1/5) activation
(Bear et al., 2004; Stoppel et al., 2017). LTD initiated by mGluR activation is dependent
on rapid, local translation of synaptic mRNAs. Within the postsynaptic density (PSD)
phosphorylated FMRP is bound to translationally stalled transcripts. Upon mGluR
activation FMRP is dephosphorylated, allowing repressed transcripts to re-enter the
translating pool and for rapid synaptic protein synthesis to occur (Santoro et al., 2012).
These nascent proteins are then involved in the internalization of α-amino-3-hydroxyl-4isoxazole propionic acid (AMPA) receptors and subsequent LTD. AMPA receptors on the
postsynaptic neuron allow Na+ influx in response to the ligand glutamate binding to the
receptor and are integral for LTP to occur. In FMRP-deficient neurons however,
translational “brakes” on these PSD transcripts are removed causing their constitutive
3

overexpression regardless of mGluR activation. Excessive AMPA receptor internalization
leads to a synaptic imbalance in favor of LTD, resulting in the hyperproduction of
immature dendritic spines that have a severely reduced function (Dölen et al., 2007;
Sidorov et al., 2013).
Naturally, studies looking at mGluR-pathway antagonists promptly followed this
discovery, in a hope that inhibiting downstream effectors in this pathway may ameliorate
some of the cognitive and behavioral deficits in FXS. Knockdown of mGluR5 expression
is capable of rescuing many of these phenotypes in mice, further supporting the mGluR
theory (Dölen et al., 2007). Additionally, multiple studies using the mGluR5 antagonist 2methyl-6-phenylethyl-pyridine (MPEP) have been able to restore proper AMPA receptor
internalization and dendritic spine morphologies in mice as well as various cognitive and
behavioral deficits in mice, zebrafish and fly models of FXS (McBride et al., 2005;
Nakamoto et al., 2007; Tucker et al., 2006; Yan et al., 2018). Recent clinical trials testing
two mGluR5 antagonists seemed optimistic at first, but rather unexpectedly showed no
significant efficacy or clinical improvement in FXS patients (Scharf et al., 2015).
Devastatingly, there are no treatments for FXS and current pharmacotherapy available for
FXS only treat specific behavioral symptoms, mood disorders or seizures. The search for
new and effective FXS therapies has been a major push in the field driving the need to
understand FMRP functions and molecular/cellular targets within the nervous system.
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Figure 1. The mGLuR theory of FXS
Used with permission of Annual Reviews, Inc., from [Molecular Mechanisms of Fragile X
Syndrome: A Twenty-Year Perspective, Michael R. Santoro, Steven M. Bray, and Stephen
T. Warren, volume 7, and Copyright (2011)]; permission conveyed through Copyright
Clearance Center, Inc.
(A) Within the postsynaptic density, phosphorylated FMRP is bound to translationally
stalled mRNAs. Following mGLuR1/5 activation FMRP is dephosphorylated, allowing
bound mRNA to reenter the translation pool. De novo protein synthesis following
mGLuR1/5 activation increases AMPA receptor (AMPAR) internalization, a requirement
for LTD. (B) Loss of FMRP function in FXS results in the loss of activity dependent
translation regulation of synaptic mRNAs by FMRP. mRNAs are maintained in a
translationally active state regardless of mGluR1/5 activation. Aberrant protein synthesis
causes an excess of AMPAR internalization and amplified LTD.
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1.1.3 FXS is caused by the disruption of the encoding FMRP protein
FXS is caused by the transcriptional silencing of the FMR1 gene due to a CGG
trinucleotide-repeat expansion in its 5’UTR (Figure 2). Normal repeat numbers range from
5-49, whereas premutation alleles contain 50-200 repeats and are referred to as such due to
their proclivity to undergo further expansion and give rise to the full mutations allele (>200
repeats) in their offspring (Fu et al., 1991). Although the premutation does not cause FXS,
it puts individuals at a higher risk of developing the neurodegenerative disorder Fragile Xassociated tremor/ataxia syndrome (FXTAS). Females have an additional risk of
developing Fragile X-Associated Primary Ovarian Insufficiency (FXPOI) which causes
severely reduced ovary function (Fink et al., 2018). The full mutation triggers a
hypermethylation event at the FMR1 promoter, preventing FMR1 gene expression (Pieretti
et al., 1991). Although complete loss of FMRP expression is the primary cause of FXS,
gene sequencing has led to the identification of over 130 single nucleotide polymorphisms
(SNPs) within the FMR1 coding region. This study sequenced the FMR1 gene of 963 males
presenting with FXS-like phenotypes, but had normal CGG repeat numbers (Collins et al.,
2010). In addition to this, there have been upwards of 100 FMR1 deletions that have been
identified in individuals, which we did not focus on in this study (Coffee et al., 2008). Of
the 130 SNPs identified, there are a handful of potentially pathogenic mutations that occur
within the coding region of the FMR1 including 3 mutations of interest that occurred within
one of the FMRP RNA-binding domains (RBDs). Before describing these point mutations,
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however, the FMRP domains and their predicted functions must be discussed in order to
understand how these mutations could be disrupting essential FMRP functions.
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Figure 2. Fragile X Syndrome is caused by disruption of FMR1 gene expression
(A) The FMR1 gene on the X chromosome contains a CGG repeat expansion between 649 repeats within its 5’UTR. Under these circumstances, the FMR1 gene is expressed,
producing a fully functional FMRP protein. Repetitive sequences, such as CGG
trinucleotide repeats, within the genome are susceptible to DNA-polymerase slippage,
where it can drastically increase repeat number. (B) CGG repeat lengths between 50-200
are still able to express the FMR1 gene normally and produce functional FMRP. However,
males with this premutation have a higher probability of developing the neurodegenerative
disorder Fragile X Tremor/Ataxia Syndrome and while females have a higher proclivity
for Fragile X Associated Primary Ovarian Insufficiency. (C) The full, loss of function
mutation occurs when CGG repeats expand beyond 200 repeats. This expansion causes
hypermethylation at the FMR1 locus inhibiting gene expression and resulting in loss of
FMRP protein. (D) However, individuals with missense point mutations within the FMR1
gene can develop FXS with normal CGG repeat numbers. These mutations are often
hypomorphic alleles that produce FMRP with reduced function and stability.
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1.1.4 Drosophila is an established model system to study FXS
In this study, we used the fruit fly Drosophila melanogaster as our model system
to study the functions of fly FMRP. FMRP is a multivalent protein with several conserved
functional domains (Figure 3A) (Siomi et al. 1993). FMRP and the related FXR1P and
FXR2P proteins are evolutionarily conserved in mammals, with a single FMRP ortholog
in Drosophila. The fly FMRP ortholog is 60% identical to human FMRP at the amino acid
level (Wan et al., 2000). Most of the conserved sequence is found within the FMRP RBDs,
suggesting their importance for FMRP function. Studying FXS and FMRP using flies as a
genetic model is advantageous as there are no FXR paralogs, which have some redundant
functions with FMRP and make it difficult to interpret results obtained from FMRP knockdown/-out experiments in mammalian models (Majumder et al., 2020). Additionally, many
of the major neural, social and behavioral FXS phenotypes found in FXS patients also
occur in the FMR1-null fly including: dendritic overelaboration, over-abundance of
neurotransmitter containing vesicles in the presynaptic space, repetitive behaviors,
courtship defects, and learning deficiencies (McBride et al., 2005, 2013).
1.1.5 FMRP domain structure and FXS-causing point mutations
1.1.5.1 FMRP contains DNA-binding tandem Tudor domains
At the amino-terminus (N-terminus) of FMRP are two DNA-binding Agenet
domains, also referred to as tandem Tudor domains (Figure 3A). These domains are
important for a nuclear function of FMRP in modulating the DNA damage response by
directly interacting with chromatin (Alpatov et al., 2014). These interactions were found to
9

be important for regulating genomic stability by reducing susceptibility to double stranded
breaks in DNA undergoing replication (Chakraborty et al., 2020).
1.1.5.2 FMRP contains three RNA-binding KH domains with elusive binding
properties
Following the tandem Tudor domains are three structured hnRNP K homology
(KH) domains KH0, KH1 and KH2 (Figure 3A). The KH1 and KH2 domains contain the
highly conserved RNA-binding GXXG loop (Hollingworth et al., 2012). The more recently
discovered KH0 domain, however, does not contain this conserved sequence suggesting
that it may not interact with RNA (Hu et al., 2015; Myrick et al., 2015a). Before this region
was identified as a non-canonical KH domain, it was reported that the KH0 domain was
responsible for protein-interactions between FMRP and the cytoplasmic FMRP-interacting
protein 1 (CYFIP1), the FMRP homolog FXR2P, and the polyribosome associated protein
82-FIP (82 kDa FMRP Interacting Protein) (Bardoni et al., 2003; Schenck et al., 2001;
Siomi et al., 1996). Interestingly, KH0 has also been shown to bind the non-coding RNA,
mammalian brain-specific cytoplasmic RNA 1 (BC1), which functions as a molecular
adaptor linking FMRP with some mRNA targets within neurons (Zalfa et al., 2003).
An individual with developmental and intellectual disability in addition to
intractable seizures was found to have an arginine to glutamine missense mutation within
the KH0 domain (Arg138Gln) (Figure 3A). Studies have indicated this mutation disrupts
FMRP association with nucleosomes and presynaptic BK channels (high conductance
calcium- and voltage- dependent potassium channels), although this doesn’t appear to be
10

occurring as a result of any significant structural changes in protein folding (Alpatov et al.,
2014; Myrick et al., 2015a). Presynaptic BK channels are important for regulating action
potential duration and neurotransmitter release, which is disrupted in Arg138Gln
hippocampal CA3 pyramidal neurons (Myrick et al., 2015b). Interestingly, this mutation
was not found to have any effect on some of the more well-characterized FMRP functions
such as mRNA binding or translation regulation, suggesting this domain may control novel
presynaptic FMRP function(s) (Myrick et al., 2015b).
Missense point mutations in the human KH1 and KH2 domains (Gly266Glu and
Ile304Asn, respectively) have been identified in two individuals with FXS (De Boulle et
al., 1993; Myrick et al., 2014). Although RNA-binding targets of the KH1 and KH2
domains remains largely elusive, these domains essential for polyribosome association
which is significantly reduced in Ile304Asn and abolished in the (Gly266Glu) mutant
(Darnell et al., 2005; Feng et al., 1997; Myrick et al., 2014). Interestingly, KH1 Gly266Glu
introduces a large, hydrophobic residue which sterically clashes with neighboring side
chains, and is predicted to disrupt KH1 domain structure (Myrick et al., 2014). The KH2
Ile304Asn mutation also results in a hydrophobic-to-hydrophilic residue mutation and
occurs within the hydrophobic binding pocket of the KH2 domain, completely disrupting
KH2 domain folding and is predicted to disrupt RNA-binding (Valverde et al., 2007).
One of the proposed mechanisms of FMRP-mediated translation regulation is via
stalling translating ribosomes on target mRNAs (Darnell et al., 2011). The structure of the
Drosophila FMRP-ribosome complex was solved using cryo-EM wherein the KH1, KH2,
11

and RGG domains were essential for this interaction (Chen et al., 2014). Interestingly, the
KH domains dock on the 80S ribosome and overlap with the peptidyl site (P-site), which
is hypothesized to prevent tRNA entry/departure and association of elongation factors,
effectively halting translation. The two canonical KH domains may function in FMRPmediated translation repression via this interaction, explaining how disruption of these
domains via FXS-causing point mutations have detrimental effects in these individuals.
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A.

B.

Figure 3. Schematic of Drosophila melanogaster FMRP
(A) All the functional domains and mutated amino acids are conserved in fly FMRP. FMRP
contains several interaction domains including: Agenet 1 and Agenet 2 (Age1 and Age2)
which are important for nuclear FMRP functions including chromatin binding (aka tandem
Tudor domains). Three hnRNP K homology (KH) domains are conserved RNA-binding
domains. The non-canonical KH0 domain also contains the nuclear localization sequence
(NLS) which allows FMRP-nuclear localization. Locations of missense point mutations
reported in three individuals with Fragile X Syndrome are indicated with red arrowheads
and annotate the conserved amino acid residue substitution and position in the Drosophila
melanogaster FMRP protein. A nuclear export sequence (NES) is positioned in between
the KH2 and intrinsically disordered region (IDR) and permits nucleocytoplasmic shuttling
of FMRP. The IDR makes up the entire C-terminus of FMRP and is shown in striped
patterning. In the middle of the IDR is the arginine-glycine-glycine rich or RGG box. The
RGG box binds G-quadruplex structures in mRNA targets. Note: domain sizes and amino
acid positions are approximate. (B) Disorder plot aligned with the FMRP protein
schematic show the C-terminus of FMRP is entirely disordered using IUPRED2.
Unstructured binding domain predictions were made using ANCHOR2 (Mészáros et al.,
2018). An IUPRED2A score of 0-0.5 is predicted to be structured, whereas scores between
0.5-1 is predicted to be unstructured.
13

Identifying mRNA targets and the RNA-recognition elements (RREs) to which the
KH domains in FMRP are binding has been highly sought after, as FMRP is known to be
a major translation regulator within neurons, and mutations within these domains cause
severe FXS. Unfortunately, there has been much disagreement between studies using
different high-throughput methods to identify FMRP-targeted mRNA motifs, specifically
for the KH1 and KH2 domains. The RREs WGGA (where W = A or U) and ACUK (where
K = G or U) were found to be enriched in FMRP RNA targets identified from
photoactivatable ribonucleoside enhanced cross-linking and immunoprecipitation (PARCLIP) and RNA immunoprecipitation followed by microarray (RIP-ChIP) analysis
(Ascano et al., 2012). WGGA is predicted to be targeted by the KH1 domain, while ACUK
is the predicted RRE of the KH2 domain. In support of these findings, Tran and others
identified an enrichment of ACUG motifs in FMRP targets (Tran et al., 2019). GACR
(where R = A/G) RREs have also been identified as putative FMRP target motifs using the
in vitro RNAcompete method (Ray et al., 2013). In this assay, the FMRP-KH domains
were incubated with an assortment of RNAs in molar excess and bound targets were
identified via microarray analysis. In 2014, Suhl and others conducted a comparative
analysis on published FMRP RNA-target datasets to determine the degree of consensus of
RREs enriched in targets identified in these studies (Suhl et al., 2014). Interestingly, they
found that GACR was the only RRE enriched in all of these datasets, whereas WGGA was
enriched to a lesser degree and only in some of these datasets. ACUK sequences which are
found ubiquitously throughout the transcriptome, did not occur with any greater frequency
14

in FMRP targets in this comparative analysis. These previously identified sequences were
pulled further into question by a recent study in 2020 which quantified FMRP-RNA
binding affinities via fluorescence anisotropy (Athar and Joseph, 2020). Neither the KH0,
KH1, nor KH2 domains were capable of binding the WGGA, ACUK, or GACR RREs,
suggesting that the FMRP KH domains may be interacting instead with more complex
RREs rather than these short sequence motifs. However, this analysis was performed in
vitro using minimal FMRP domain-fusions which may not be physiologically relevant.
The lack of consensus between the different binding motifs identified for the KH
domains could be due to differences in cell-type specific interactions that are being
characterized. FMRP is expressed throughout the body and likely regulates different
transcript populations in a cell-type dependent manner. It will be important to identify
neuronal transcript targets and RREs identified by these KH domains using more consistent
analyses in similar tissue/developmental stages in the future in order to gain a better
understanding of their contribution to FMRP-mediated translation repression.
1.1.5.3 FMRP is a nucleocytoplasmic shuttling protein
Within the KH0 domain is a Nuclear Localization Sequence (NLS), which as the
name suggests, is important for localizing FMRP to the nucleus (Kenny and Ceman, 2016).
FMRP also contains a Nuclear Export Sequence (NES) between the KH2 domain and the
C-terminal intrinsically disordered region (IDR), which together with the NLS, permits
nucleocytoplasmic shuttling of FMRP (Eberhart et al., 1996). In addition to having a
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function within the nucleus, FMRP is better known for its function in shuttling nascent
mRNA targets out of the nucleus and into the cytoplasm (Hsu et al., 2019).
1.1.5.4 The C-terminal RGG box confers FMRP-target specificity
Following the NES, mammalian FMRP contains an arginine-glycine-glycine rich
(RGG) box within its C-terminal intrinsically disordered region, or IDR (Figure 3AB). The RGG box is an unstructured RBD that interacts with secondary structures in RNA
targets such as stem loops and G-quadruplexes. These RREs are enriched in many FMRPtargets and are speculated to be one of the major features specifying FMRP-targets
(Bechara et al., 2009; Brown et al., 2001; Darnell et al., 2001; Phan et al., 2011; Zhang et
al., 2014). Interestingly, the RGG domain was recently shown to be important for the
localization of transcripts containing G-quadruplex structures within their 3’untranslated
regions (3’UTRs) to neurites (Goering et al., 2020). This supports previous findings
reporting the enrichment of G-quadruplex structures within 3’UTRs of neuritically
localized transcripts (Subramanian et al., 2011). Importantly, while the KH domains are
important for translation repression, the RGG box is thought to contribute an mRNAbinding/localization function. However, the RGG domain is weakly conserved in
Drosophila, and it is unclear whether it is capable of binding to G-quadraplex sequences
in flies (Vasilyev et al., 2015).
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1.1.5.5 The C-terminal half of FMRP is intrinsically disordered and is capable of
promoting liquid-liquid phase separation in vitro
IDRs, also termed low-complexity domains (LCDs), are regions within a protein
that have low amino acid complexity, and are typically deficient in bulky hydrophobic
residues which drive large folding events within proteins (Yang et al., 2019). As such, these
domains inherently lack a well-defined structure but are sometimes capable of adopting a
3D structure when the protein is bound to a substrate via other interaction domains. A
substantial amount of evidence indicate that these sequences are capable of driving the
formation of membraneless organelles (MLOs) in cells via the process of liquid-liquid
phase separation (LLPS) (Brangwynne et al., 2009; Shin and Brangwynne, 2017).
LLPS is the reversible process by which a macromolecular solution spontaneously
or actively demixes to form two distinct phases that can dynamically exchange material
with one another (Berry et al., 2018; Boeynaems et al., 2018). This process can be likened
to oil demixing from water and forming a dense liquid oil droplet within the dilute liquid
water environment. This biological phenomenon is driven by weak inter- and intramolecular interactions between proteins and nucleic acids, which upon reaching a “critical
threshold” or “saturation limit” undergo a phase transition and form a non-membrane
bound droplet (Figure 4A). These droplets have been coined many different names
including, but not limited to, granules, bodies, condensates, MLOs, liquid droplets, foci,
puncta, assemblies, and bodies. For the sake of simplicity, these will be referred to as
“granules” or “MLOs” below. The formation of phase separated granules within a cell
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serves as a means for the tight spatiotemporal regulation of diverse biomolecular processes
such as ribosome biogenesis (Falahati and Wieschaus, 2017), gene expression (Al-Husini
et al., 2018; Molliex et al., 2015), cell differentiation (Liu et al., 2020), and cell receptor
assembly and signaling (Banjade and Rosen, 2014; Su et al., 2016).
Many proteins that drive LLPS contain IDRs. IDRs promote phase separation due
to their propensity to form weak-intermolecular interactions with RNAs, folded proteins
and other IDRs (Protter et al., 2018). The promiscuity of the interactions of IDRs within
proteins are suggested to decrease the critical concentration of nucleic acid or protein
interactors needed to phase separate, by enhancing the overall strength of multivalent
interactions between molecules (Figure 4B) (Protter et al., 2018). Interestingly, IDRcontaining proteins are common villains in neurodegenerative diseases due to their
propensity to promote liquid-to-solid phase transitions which form pathological protein
aggregates or amyloid fibrils (e.g. hnRNPA1, TDP-43 and FUS) (Babinchak et al., 2019;
Lin et al., 2015; Molliex et al., 2015; Murthy et al., 2019). When mutated, these phase
separating proteins commonly cause dominant-negative phenotypes and form irreversible
fibrils or aggregates via homotypic or heterotypic interactions, respectively (Mathieu et al.,
2020).
One model describing the composition and dynamicity of phase separated granules
describes these structures as containing cores and shells, in which an initially heterogenous
granule is remodeled into smaller dense “cores” surrounded by a more dynamic “shell”
(Figure 4A) (Jain et al., 2016). This has been described particularly for stress granules
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(SGs), but other biological MLOs are likely to be similarly organized. Molecules within
the initial granule mature and form more stable interactions, nucleating cores which are
synonymous with the immobile fraction of MLOs. This model also predicts that multiple
separate cores can exist within a larger granule, all of which are surrounded by a
dynamically exchanging shell. This shell contains molecules that make up the mobile
fraction of MLOs. It’s thought that mutations in stable core constituents may result in the
formation of pathological aggregates, contributing to neurodegenerative disease (Lin et al.,
2015).
Although IDRs are commonly thought to be the defining feature for a proteins
ability to phase separate, multivalency of interaction domains is the actual driver for this
process to occur in vivo (Boeynaems et al., 2018; Choi et al., 2020; Martin and Holehouse,
2020). The valency, or number of domains capable of undergoing inter- and intramolecular
interactions in a protein is directly related to the critical concentration at which LLPS will
occur, with a protein of higher valency phase transitioning at lower concentrations than a
protein with lower valency (Figure 4B) (Li et al., 2012). Multivalency is crucial for this
process by allowing multiple interactions to occur between a single molecule and multiple
protein and/or RNA partners, effectively forming a biopolymer, or ribonucleoprotein
complex (RNP). These RNPs are then often capable of interacting heterogeneously with
other RNPs, greatly increasing protein and nucleic acid concentrations within a particular
subcellular location. Upon reaching a particular saturation limit, interacting RNPs
spontaneously form a droplet via LLPS.
19

Interestingly, the entire C-terminal half of mammalian and fly FMRP is intrinsically
disordered (Figure 3B) (Tsang et al., 2019). This indicates that the IDR may have a
substantial impact on how FMRP interacts with other biomolecules to form MLOs
important for regulating gene expression. FMRP is a multivalent protein capable of
interacting with DNA, RNA and proteins (Figure 3A. Interestingly, FMRP has been
extensively documented as a component of many different phase separated granules within
cells that function in modulating RNA translation and stability including: polyribosomes,
RNA Processing bodies (P-bodies), SGs, and neuronal granules (NGs) (Barbee et al., 2006;
El Fatimy et al., 2016; Gareau et al., 2013a; Stefani et al., 2004). Interestingly, the
disordered C-terminus of human FMRP is sufficient to reversibly drive LLPS in a
phosphorylation-dependent manner in vitro (Tsang et al. 2019). It has been proposed that
this may serve as a mechanism for FMRP to regulate activity-dependent translation in
neurons (Kim et al. 2019). However, precisely how FMRP is able to interact with a
diverse subset of cytoplasmic granules and what its functions are within them has yet
to be elucidated. In order to gain a better understanding of what the functions of FMRP
within biomolecular condensates are, we need to first understand the breadth of known
functions that FMRP has in the regulation of gene expression.
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A.

B.

Figure 4. Liquid-Liquid Phase Separation
(A) Left: Proteins and RNAs form mRNP complexes that are soluble within the
surrounding dilute liquid environment. Middle: Increased local protein and/or RNA
concentration can cause phase separation to occur, forming a dense liquid droplet. These
droplets are held together by weak multivalent interactions, are reversible and dynamically
exchange with the surrounding dilute phase. Right: mRNP interactions within phase
separated granules are capable of maturing over time and form stable cores within a more
dynamic shell. These cores are formed by stably interacting mRNPs which minimally
exchange with the more dynamic shell. Figure adapted from (Jain et al., 2016) (B) Left:
Proteins are evenly distributed in a system and undergo phase separation above a critical
concentration, forming liquid droplets. These droplets are stable so long as the protein
concentration remains higher than the critical concentration. Liquid droplets dissolve if
protein levels drop below the critical concentration. Right: The critical concentration for
phase separation is reduced in proteins with higher valency or for proteins that interact
more strongly. Figure adapted from (Alberti, 2017).
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1.2 FMRP regulates translation and mRNA transport within granules
1.2.1 Models of FMRP-mediated translation regulation
FMRP has a clear function in regulating the translation of many proteins within
neurons as indicated by the loss of FMRP causing significant alterations in protein
expression (Richter and Zhao, 2021). Strong evidence showing the crucial role of FMRP
in translation inhibition was the observation that proteins in FMR1-KO mice incorporated
significantly more
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S-methionine, reporting an up to 20% increase in protein synthesis

(Dölen et al., 2007; Udagawa et al., 2013). FMRP is further implicated as a translation
regulator as it binds over 1,000 transcripts predominantly within their coding sequences
(CDS), and is found to be associated with stalled ribosomes in polyribosome fractions
(Darnell et al., 2011; Li et al., 2020; Maurin et al., 2018; Sawicka et al., 2019; Das Sharma
et al., 2019; Stefani et al., 2004). FMRP regulates mRNA translation and stability in both
the pre- and postsynaptic space. These regulated transcripts encode proteins that are
important for synaptic transmission, small GTPase signaling, dendritic outgrowth, and
ionotropic glutamate receptor activity (Darnell et al., 2011; Tran et al., 2019). Moreover,
FMRP is responsible for regulating multiple stages of the mRNA life-cycle including
translation initiation and elongation, degradation inhibition, and translation repression of
target mRNAs via the microRNA RISC (miRISC) pathway, within messenger RNP
(mRNP) granules (Lai et al., 2020; Li et al., 2008; Richter and Zhao, 2021). Below, the
focus will be on FMRP functions in repression of translational initiation and elongation,
and its regulation of mRNA stability within different populations of mRNP granules.
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1.2.1.1 Regulation of translation initiation
As previously mentioned, FMRP is responsible for differentially regulating a large
subset of neuronal transcripts, and is able to do so at different points of the mRNA life
cycle. Although it is not the major mechanism of FMRP-mediated translation repression,
FMRP regulates translation initiation in an activity dependent manner (Napoli et al., 2008).
FMRP interacts with the eukaryotic initiation factor 4E binding protein, CYFIP1 (Schenck
et al., 2001). CYFIP1 is involved in targeted translation suppression and actin
polymerization, two processes important for dendritic spine morphogenesis which is
affected in FXS (De Rubeis et al., 2013). Within neurons, FMRP forms an mRNP complex
with CYFIP1, and is able to recruit CYFIP1 to specific mRNAs such as the dendritically
localized Arc, camkii, Map1B, and APP (Napoli et al., 2008). CYFIP1 then binds to the 5’
7-methylguanosine (m7G) cap binding protein eIF4E, inhibiting the formation of the eIF4F
complex at the m7G cap. Without the eIF4F scaffold the 43S preinitiation complex with
the small ribosomal subunit cannot be recruited to the transcript and cap-dependent
translation initiation is inhibited (Hinnebusch, 2014). Following activation of mGluR at
the PSD, CYFIP dissociates from eIF4E allowing translation to proceed (Napoli et al.,
2008). Interestingly, CYFIP1 interacts with multiple genes associated with neurological
disorders including ASDs, intellectual disabilities, attention deficit hyperactivity disorder
(ADHD), schizophrenia, and Alzheimer’s disease (AD), in addition to FXS, implicating its
importance in regulating synaptic plasticity (De Rubeis et al., 2013). The FMRP-CYFIP1
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initiation suppression complex may function to regulate only a particular subset of genes,
as this is not the major mechanism of FMRP-mediated repression (Richter and Zhao, 2021).

1.2.1.2 Regulation of translation elongation
The observation that FMRP is found predominantly within polyribosome fractions
and binds transcripts within their CDS, suggests that the major mechanism by which FMRP
represses translation occurs at the level of elongation (Shah et al., 2020). Indeed,
polyribosome runoff experiments have shown that FMRP associates with mRNAs and
blocks ribosomal translocation as evidenced by high levels of ribosome-occupancy on
FMRP-bound transcripts following puromycin treatment (Darnell et al., 2011). Puromycin
stimulates premature termination of actively translating ribosomes, while having no impact
on stalled ribosomes (Stefani et al., 2004). Ribosomal stalling as a mechanism of regulating
translation was recently supported in a study showing a reduction of ribosomal pausing on
FMRP-regulated transcripts in an FMR1-KO mouse model (Das Sharma et al., 2019).
Additionally, over 300 mRNAs repressed by FMRP have been found to have increased
ribosomal stalling (Shu et al., 2020). Although it’s evident that FMRP regulates translation
via ribosome stalling, how it’s functioning as a molecular brake on specific subsets of
neuronal transcripts has been debated throughout the years.
One model predicts that FMRP stalls ribosome translocation by blocking the
association of tRNA and other elongation factors with the ribosome (Chen et al., 2014;
Richter and Zhao, 2021). Using cryo-EM, the KH domains of Drosophila FMRP were
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shown to interact directly with the ribosome near the ribosomal P-site, suggesting that it
may block the addition of new amino acids to the elongating polypeptide chain (Chen et
al., 2014). Additionally, the RGG box in FMRP bound near the A-site of the ribosome.
This puts the RGG box in close proximity to putative G-quadruplex secondary structures
in target mRNAs where it could be bound to the transcript. From this, it can be inferred
that when FMRP is bound to G-quadruplex structures in target transcripts via the RGGbox, it is also able to bind translocating ribosomes via the KH domains and block
elongation. However, these FMRP-ribosome interactions were shown in vitro and outside
of the context of bound mRNA. Further studies on how FMRP interacts with translating
ribosomes are required to gain a better understanding of this relationship.
Another model predicts that FMRP sterically hinders translocation via its ability to
bind transcripts within and throughout their CDS via optimal codons (Darnell et al., 2011;
Richter and Zhao, 2021). Within neurons, FMRP mRNA targets are enriched with optimal
codons, which are codons that correspond with highly abundant tRNAs. FMRP
preferentially interacts with and stabilizes transcripts with this optimal codons bias (Shu et
al., 2020). In support of this model, transcripts with optimal codon bias are
disproportionately down-regulated in FMRP-deficient mice (Sawicka et al., 2019;
Thomson et al., 2017). It has been predicted that FMRP increases mRNA stability by
binding and protecting mRNAs via these optimal codons and blocking an unidentified
nuclease from degrading bound transcripts (Shu et al., 2020). However, the mechanism by
which FMRP preferentially interacts optimal codons to control these processes has yet to
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be elucidated and there are still a lot of questions that need to be answered for this recent
model.
In summary, FMRP is able to repress translation of specific subsets of mRNA
targets using vastly different mechanisms, which could enable cells to fine-tune expression
at different stages in development, in different tissues, or even in spatially distinct areas
within the cell (e.g. different populations of granules). However, how FMRP is able to
differentially regulate translation is still unknown. We speculate that this is most likely
determined by the particular mRNP complex with which FMRP is associated.
1.2.2 Regulation of mRNA in mRNP complexes
From the onset of transcription until decay, mRNAs are painted with RBPs,
forming an mRNPs which choreograph mRNA fate within the cell. RBPs interact with
transcripts via a number of RNA secondary structures or specific sequences located within
the untranslated regions (UTRs), introns and exons. Motifs within the UTRs are typically
important for directing cellular localization and increasing mRNA stability (Taliaferro et
al., 2016). Interestingly, transcripts enriched within distal axonal and dendritic
compartments of neurons, have considerably longer 3’UTRs which offers more RREs for
miRNA and RBPs to interact with and promote stabilization during transport (Taliaferro et
al., 2016; Tushev et al., 2018). FMRP is found within many different mRNP complexes
which differ in protein content and molecular function including polyribosomes, SGs, Pbodies, and NGs. Polyribosomes contain mRNAs, ribosomes, translation factors, and other
RBPs that can either promote or repress translation. As previously discussed, FMRP
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associates with polyribosomes where it functions in ribosome stalling during translation
elongation. Polyribosomes are the major mRNP granule which FMRP localizes to and
functions within. However, FMRP is also able to stabilize and translationally repress
mRNAs within other mRNP complexes.
1.2.2.1 FMRP promotes stress granule assembly
SGs are a type of MLO that form rapidly in response to cellular stress and contain
transcripts that are stalled at the pre-initiation phase of translation. A number of stressors
including heat/cold shock, oxidative stress, ER stress, osmotic stress, and UV irradiation
can induce the formation of SGs where mRNAs are translationally stalled to reduce energy
expenditure from protein production (Protter and Parker, 2016). SGs also serve as dynamic
triage units within the cell where the fate of transcripts is determined and mRNAs are
directed for repression, degradation, or storage. Depending on the type of stress, transcripts
will either be stabilized and translationally repressed until the cell is no longer stressed and
re-initiation of translation can resume, or targeted for degradation (Anderson et al., 2015).
FMRP has been identified as a core SG component and may be involved in shuttling
translationally repressed transcripts from polyribosomes to SGs (Fu et al., 2020; Mazroui
et al., 2002). Although FMRP is not required for SG nucleation, loss of FMRP reduces
mRNA localization to SGs and reduces SG assembly (Didiot et al., 2009). FMRP maintains
translation repression in its phosphorylated state. Interestingly, phosphorylation of residues
within the C-terminal IDR of FMRP promotes its phase separation with CAPRIN1, a
protein that promotes SG assembly (Kim et al., 2019). Assembly of the FMRP-CAPRIN1
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complex may be a mechanism by which mRNAs are recruited to stress granules. However,
the precise function of FMRP within SGs is largely unknown.
1.2.2.2 FMRP interacts with RNA Processing bodies within neurons
FMRP also interacts with P-bodies to regulate mRNAs (Barbee et al., 2006; Cougot
et al., 2008; Zalfa et al., 2006). P-bodies are mRNP granules containing nontranslating
mRNAs and RBPs involved in deadenylation, 5’ 3’ mRNA decay, mRNA storage and
repression via the RNA-induced silencing complex (RISC) in somatic cells (Anderson and
Kedersha, 2006; Standart and Weil, 2018). Some of the core components required for
mRNA decay in P-bodies include the deadenylation complexes, decapping enzymes and
enhancers of decapping (Coller and Parker, 2005; Eulalio et al., 2007; Ingelfinger et al.,
2002; Luo et al., 2018; Parker and Sheth, 2007). In contrast to SGs, ribosomal subunits and
most translation initiation factors are absent from these MLOs (Parker and Sheth, 2007;
Teixeira et al., 2005). A subset of FMRP localizes to mRNP transport granules structurally
related to P-bodies throughout neurons, illustrating yet another mechanism by which
FMRP mediates translation repression and transcript stability (Barbee et al., 2006; Cougot
et al., 2008). Although FMRP associates with P-bodies, its function within these structures
has yet to be elucidated. FMRP associates with miRNAs and several components of the
RISC pathway including Ago1, Ago2 and Dicer (Cheever and Ceman, 2009; Jin et al.,
2004; Muddashetty et al., 2011). It has been speculated that FMRP may be involved in
mediating translation repression in P-bodies via the RISC complex.
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1.2.2.3 FMRP regulates RNA transport within neuronal granules
Neurons are able to control individual synaptic processes by fine-tuning the
distribution and regulation of mRNAs within synapse-localized neuronal granules (NGs).
NGs are a specialized MLO found throughout the brain and are enriched with cytoskeletal
proteins, ribosomal subunits, translation regulators, RBPs and translationally repressed
synaptic mRNAs (Antar et al., 2005; Banerjee et al., 2018; El Fatimy et al., 2016; Merrill
et al., 2005; Miyashiro et al., 2003). Interestingly, in mouse brains these complexes also
show a high degree of overlap with polyribosomes suggesting NGs may develop from
stalled polyribosomes (El Fatimy et al., 2016).
Densely packaged NGs form within the soma and transport mRNAs in a
translationally repressed state through dendrites and axons out to synaptic terminals (Figure
5). Forming a compact granule is necessary to prevent the loss of material due to
hydrodynamic drag during rapid, motor-dependent transport through neurites (Alberti,
2017; Brangwynne et al., 2009). NGs are bidirectionally transported via microtubules
between the soma and synaptic densities, revealing a recycling mechanism of NG
components back to the cell soma, in addition to their delivery out to synapses (Bassell and
Warren, 2008). Anterograde transport out to distal neurites occurs via the motor protein
kinesin, while retrograde transport is dependent on the dynein motor protein (Carson et al.,
2001; Kanai et al., 2004; Otero et al., 2002). At the synapse, NGs are maintained within
the synaptic density and disassemble in response to local synaptic activation, permitting
rapid protein synthesis in response to an acute stimuli (Buxbaum et al., 2014).
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Within neurons, FMRP associates with NGs in the soma, neurites and at synaptic
densities and it is proposed that FMRP regulates many mRNA targets within these
structures (El Fatimy et al., 2016) However, FMRP occupies only a subset of NGs
suggesting it may be essential for the spatiotemporal regulation of particular neuronal
mRNAs (Barbee et al., 2006; El Fatimy et al., 2016). FMRP and the FMR1 mRNA are both
found within the PSD, suggesting the necessity for local translation of FMRP at these sites
(Antar et al., 2004). Perhaps FMRP is not the major regulator of mRNAs during transport,
but is instead required for translation repression out at the synapse. While studies using the
MS2-tagging method show a requirement for FMRP in localizing target transcripts out to
neurites, others indicate that FMRP is not required for NG transport (Dictenberg et al.,
2008; Estes et al., 2008; Kao et al., 2010). Recently, Goering and others showed that the
RGG box was required for the localization of mouse FMRP and G-quadruplex containing
transcripts out to neurites using subcellular fractionation followed by high throughput
sequencing (Goering et al., 2020). As indicated earlier, one of the major cellular defects in
FXS is dendritic overgrowth due to aberrant protein synthesis at the synapse. This indicates
that transcripts are localized out at synaptic densities even in the absence of FMRP, and
that FMRP is not required for mRNA transport within NGs. Altogether, there is a general
lack of understanding of what role FMRP has within NGs and how it interacts with these
MLOs.
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Figure 5. Model for FMRP function in NGs
1) FMRP binds target transcripts within the nucleus forming an mRNP. 2) This mRNP is
shuttled out of the nucleus into the soma where ribosomes assemble on mRNAs and
translate polypeptides until FMRP is phosphorylated which stalls translation. These
translationally stalled complexes can then assemble with motor adaptors and other factors
to form a NG. 3) The NG then associates with the kinesin motor protein and is translocated
out to distant synaptic densities via microtubules. 4) After reaching a synaptic destination,
the NG is released from the motor protein and maintained in the PSD. 5) Upon synaptic
activation of the mGluR1/5, 6) FMRP is dephosphorylated and releases translation
repression on its target transcript. 7) The transcript rapidly resumes translation, producing
nascent protein in an activity dependent manner. 8) FMRP is either retained in the PSD or
9) transported back to the soma via dynein motor proteins. Figure adapted from (Bassell
and Warren, 2008).
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1.3 Summary
FMRP is an RBP important for regulating >1,000 mRNAs, many of which function
in learning and memory formation. Even though its function as a repressor of translation is
clear at both the initiation and elongation phase, how it is able to spatiotemporally regulate
such a diverse population of transcripts has yet to be elucidated. One of the major cellular
functions of FMRP is its ability to interact with distinct phase-separated granules.
Organization by phase separation is speculated to be an important cellular phenomenon
that allows for the compartmentalization of molecules important for specific processes
while still permitting for dynamic exchange with the surrounding environment. The
propensity of FMRP to localize to granules suggests that this is important for its function.
Whether specific interaction domains of FMRP are required for recruitment to different
granules is unknown. The specific RRE identified by the KH domains remains enigmatic,
although the ubiquitous short sequences are the most likely candidate. We predict the KH
domains are crucial for strengthening overall interactions within FMRP granules via these
highly enriched RREs, while more specific interactions are contributed by the other
domains. Here we present the central hypothesis that the KH domains of FMRP are
required for FMRP granule formation. To test this hypothesis, we examine the impact of
two FXS-causing missense point mutations in the KH domains on FMRP granule
formation and function. We predict that multivalent interactions via these low specificity
KH domains, promotes the formation of FMRP-interacting granules and more specifically,
FMRP-positive NGs in vivo.
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CHAPTER TWO: MULTIVALENT INTERACTIONS DRIVE FMRP GRANULE
FORMATION IN DROSOPHILA S2 CELL CULTURE

2.1 The FMRP IDR functions cooperatively with the KH domains to form granules
FMRP has been well characterized in its ability to localize to different MLOs
including SGs, P-bodies, Fragile X granules (FXGs), and NGs (Barbee et al., 2006; Christie
et al., 2009; Gareau et al., 2013a; Lee et al., 2010; Li et al., 2009). Like human FMRP, the
entire C-terminus of Drosophila FMRP is predicted to be disordered (Figure 3B). IDRs
within RBPs have been shown to drive the formation of granules through the process of
LLPS. Although the IDR of FMRP has been shown to promote droplet formation in vitro,
the dependency of the IDR in granule formation in vivo has yet to be elucidated (Tsang et
al., 2019). More specifically, little is known about what role the IDR plays in the context
of the other RBDs in the ability of FMRP to localize to or form granules. To address this
question, we first constructed a series of IDR and KH domain mutants with an N-terminal
EGFP-tag (Figure 6A). We then expressed these constructs in transiently transfected
Drosophila Schneider 2 (S2) cells to determine how they impact FMRP granules.
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Similar to what has previously been shown by others, our EGFP-FMRP (WTFMRP) construct forms numerous, characteristically small, spherical granules (Figure 6B;
Gareau, Martel, et al. 2013; Gareau, Houssin, et al. 2013). We were initially interested in
determining if the IDR of fly FMRP, referred to here as IDR, was necessary and sufficient
to drive the formation of FMRP granules in S2 cells. As with its human ortholog, the IDR
was sufficient to induce FMRP granules in transfected cells (Figure 6C). Interestingly,
expression of the IDR alone is not capable of forming granules in all cells, with IDRgranules forming in approximately 25% fewer cells than WT-FMRP. This suggests that
other domains within the N-terminus of FMRP likely contribute to the formation of (or the
interaction with) granules in vivo. In support of this hypothesis, the structured N-terminus
of FMRP (∆IDR), which contains the DNA-binding tandem Tudor domains and the three
protein- and RNA-binding KH domains, is also capable of forming granules, albeit at a
significantly lower frequency (~26%). Interestingly, ∆IDR was able to form granules even
at lower expression levels than WT-FMRP (Figure 6D). It’s important to note, that we
cannot conclude whether this indicates that FMRP is able to form granules without the IDR
or if this construct is able to interact with already formed FMRP granules (or another MLO)
via its N-terminal functional domains. Regardless, the loss of the either the N- or Cterminal domains significantly reduces the formation of FMRP granules in vivo.
Based on these observations, we speculated that the two major RBDs within the Nterminus, KH1 and KH2, may play an important role in promoting the formation of FMRP
granules by working in cooperation with the IDR, as multivalent interactions are what drive
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LLPS in the cellular context. Indeed, we found that by adding back both KH domains
(KH+IDR) this granule phenotype was rescued, with over 90% of cells forming granules
(Figure 6C). These data support recent evidence suggests that although IDRs are important
for the biogenesis of MLOs, multivalent interactions contributed by other interaction
domains is required for more physiological granule formation (Banani et al., 2016). More
specifically, this suggests that the KH1 and KH2 domains cooperate with the IDR to form
FMRP granules, in vivo.
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Figure 6. The IDR functions cooperatively with the KH domains to form FMRP
granules in S2 cells
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(A) Schematic of FMRP showing each of the RBDs in light blue boxes and its IDR which
is indicated by grey and white stripes (top). IDR mutants that were made in this study are
shown below WT-FMRP and amino acid deletions are annotated with thin lines. Premature
stop codon was added before the IDR domain (amino acids 374-682) in ∆IDR construct.
For IDR, the first 373 amino acids were deleted from FMRP. Both KH1 and KH2 domains
are fused to the IDR in the KH+IDR mutant. The first 226 amino acids up to KH1 domain
were deleted as well as the region between the KH2 and IDR domains (336-373). Each of
these constructs were made within an N-terminally tagged EGFP vector. (B)
Representative images of EGFP-FMRP mutant granule phenotypes in S2 cells. These
images show the major FMRP phenotype produced by these mutants. Scale bar: 2µm. (C)
Quantification of the percentage of transfected cells forming FMRP granules (mean ± S.E.;
n≈100 cells in triplicate). (D) Western blot analysis of EGFP protein levels in untransfected
cells or cells transiently transfected EGFP and EGFP-FMRP mutant constructs. α-tubulin
was used as a loading control. IB= immunoblot. Statistical analysis was done by ordinary
one-way ANOVA followed by Holm-Šídák's multiple comparisons test.
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2.2 FXS-causing missense mutations in the KH domains disrupt granule formation
Disease-causing missense mutations in the KH1 and KH2 domains of hsFMRP
(Gly266Glu and Ile304Asn, respectively) are predicted to disrupt proper folding of KH
domains via steric disturbance. Disruption of protein structure by these mutations results
in the loss of several important FMRP functions including mRNA-binding, AMPA
receptor trafficking and polysome association (Darnell et al., 2005; Myrick et al., 2014;
Valverde et al., 2007). To better understand what role(s) the KH1 and KH2 domains have
in FMRP granule formation, we made the analogous point mutations in the evolutionarily
conserved residues of the Drosophila FMRP ortholog, Gly269Glu and Ile307Asn,
hereafter referred to as KH1* and KH2*, respectively (Figure 7A) (Valverde et al., 2007).
First, we transfected S2 cells with these EGFP-tagged point mutants to see what
impact this had on FMRP granule formation (Figure 7B). Interestingly, we observed a twofold decrease in the ability of cells transfected with KH1* to form granules, while KH2*
had no effect (Figure 7C). This suggests that the KH1, but not the KH2 domain, is required
for de novo assembly or recruitment to pre-existing granules. We also saw a significant
reduction in the ability to form granules in cells expressing the KH1*KH2* double mutant
which disrupts both KH domains. KH1*KH2* did not have as robust of an effect on
granules as KH1*, instead representing an intermediate between the mutants. Higher local
concentrations of protein drive granule formation, and lower expression of the KH1* and
KH1*KH2* mutants could explain why we saw fewer granules in these cells (Bolognesi
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et al., 2016; Li et al., 2012). However, these mutants were each expressed at similar levels
suggesting this is not the reason we see fewer granules in these mutants (Figure 7D).
As a control, we also made a construct called ΔKH in which both the KH1 and KH2
domains were removed (Figure 7A). This has been used in previous studies looking broadly
at the role of functional domains in FMRP granule formation and dynamics in S2 cells
(Gareau et al. 2012). Consistent with published results, ΔKH had no effect on the ability
of FMRP to form granules in vivo (Figure 7C). Together, these data suggest that the KH1,
but not KH2, domain is required for FMRP granule formation in S2 cells.
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Figure 7. The KH1 FXS-causing point mutation disrupts FMRP granule formation
(A) Schematic representation of FMR1 variants used in this study. Arrow heads point to
location on a Drosophila melanogaster FMRP protein where the analogous FXS-causing
missense mutation is located at the conserved residues. Deletion of the two adjacent KH
domains is annotated with a break in the FMR1 gene between amino acids 225-236. (B)
Representative confocal images of transiently transfected EGFP or EGFP-FMRP
constructs in S2 cells. Scale bar: 2µm. (C) Quantification of the percentage of transfected
S2 cells that formed EGFP-FMRP granules. Average is shown in the top of each bar (mean
± S.E.; n≈100 cells in triplicate). (D) Western blot analysis of FMR1 and EGFP protein
levels in untransfected cells or cells transiently transfected EFGP and EGFP-FMRP mutant
constructs. α-tubulin was used as a loading control. IB= immunoblot. Statistical analysis
was done by ordinary one-way ANOVA followed by Holm-Šídák's multiple comparisons
test.
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In addition to differences in their ability to form granules, we noticed distinctive
morphological phenotypes in several of our constructs. We classified these morphological
differences into two categories: 1) “normal” granules, which were generally round in shape
with diameters of ~ 200-1,000 nm, and 2) amorphic granules, which were considered to be
any type of non-round granule. Although each construct could induce the formation of
amorphic granules, this typically occurred in less than 10% of cells (Figure 8A-B). EGFPtagged IDR, KH+IDR, KH1*, KH1*KH2*, and ∆KH resulted in the formation of granules
that were morphologically indistinct from WT-FMRP granules. In contrast, 70% of ∆IDR
(Figure 8A) and ~ 50% of KH2* (Figure 8B) granule forming cells contained amorphic
granules that took up large volumes within the cell, oftentimes with diameters greater than
1,000 nm. This suggests that the IDR and KH2 domain may be involved in forming
interactions with additional factors that restrict the size and shape of FMRP granules.
Interestingly, round granules in KH1*KH2* and ∆KH were very large, reminiscent of
liquid-like droplets that have fused into larger structures (Figure 7B) (Brangwynne et al.,
2009). This further suggests that the KH domains may be regulating granule size in S2
cells.
We also noticed differences in the number of granules present within these cells
which led us to quantify the average number of granules each mutant was able to form. To
our surprise, neither the IDR (Figure 8C) or KH mutants (Figure 8D) were able to
recapitulate WT granule numbers, with an at least three-fold reduction in each mutant.
However, KH2* formed more granules than any of the other constructs. This further
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indicates that this mutation does not substantially impact FMRP granule formation in vivo
(Figure 8D). Altogether, these data suggest that the KH domains and IDR are cooperating
to regulate FMRP granule formation in vivo. Loss of any single domain alters but does not
abrogate granule formation, morphology or number, suggesting that FMRP granule
formation is dependent on multivalent interactions.
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Figure 8. The KH2 domain and IDR regulate FMRP granule morphology
Comparisons of the two major morphological phenotypes observed in the (A) FMRP-IDR
mutants and the (B) FMRP-KH mutants. Spherical granules (black bars) were always
present in cells, although some also coincided with non-spherical, amorphic granules (grey)
that often took up much larger volumes of the cell. Cells were categorized as amorphic if
at least one granule within the cell was amorphic. A small percentage of all cells formed
amorphic granules. Spherical granules ranged in size from ~200-1,000 nm (n=100 cells).
Comparison of the average number of granules per cell in the (C) FMRP-IDR mutants and
the (D) FMRP-KH mutants, normalized to cell area, µm2 (mean ± SE; n=15 cells).
Statistical analyses were done by Brown-Forsyth ANOVA followed by Dunnett’s T3
multiple comparisons test.
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2.3 The IDR promotes FMRP-core formation, while the KH domains alter the
dynamics of the outer shell in FMRP granules
Thus far, we have demonstrated that the formation of FMRP granules is driven, in
part, by multivalent interactions involving the modular N-terminal RBDs and the Cterminal IDR. FMRP is able to undergo LLPS in vitro (Tsang et al., 2019). FMRP granules
in our study share some classic features with phase separated droplets. Droplets are
characterized by forming round structures, which we see with our FMRP granules (Figure
6A & 7A). Another common feature is their propensity to coalesce into a single larger
droplet upon contact with one another (Brangwynne et al., 2009). Although FMRP granules
move throughout the cell and come into contact with one another, we rarely saw them
remain fused together, and rather would interact briefly and then split off (data not shown).
Liquid droplets are also characterized by their dynamic ability to rapidly reorganize and
exchange with their surrounding environment (Shin and Brangwynne, 2017). It has
previously been shown that deletion of the KH domains in FMRP significantly reduces the
ability of FMRP to exchange between granules and the cytosol (Gareau et al., 2013b).
Thus, we predicted that one important function for the individual KH domains may be to
modulate FMRP granule dynamics (Goering et al., 2020; Tsang et al., 2019).
To study the dynamics of FMRP in granules in transfected S2 cells, we conducted
Fluorescence Recovery After Photobleaching (FRAP) experiments. First, we examined the
independent and collaborative roles of the IDR and KH domains in FMRP granules
dynamics. Interestingly, WT-FMRP formed relatively stable granules (Figure 9A). The
45

IDR and ∆IDR in contrast rapidly recovered their exchangeable pools, suggesting that
domains within the N-terminus and C-terminus may somehow cooperate to stabilize WT
granule dynamics (Figure 9A-D). In support of this, fusing the KH domains to the IDR
helped stabilize granule interactions, recovering somewhat more slowly following
photobleaching (Figure 9A-B and 9D). However, these granules were still significantly
more dynamic than WT, suggesting additional N-terminal domains are also contributing to
stabilizing FMRP-interactions within granules.
A current model suggests that membraneless SGs are made up of stable cores from
which there is little or no exchange, and are surrounded by a highly exchangeable shelllike structure (Jain et al., 2016). In FRAP experiments, it is predicted that proteins within
the non-recovering immobile fraction represent stable cores, whereas the mobile fraction
represents the dynamic shell (Figure 4C). Approximately 30% of WT makes up these
stably interacting cores, while the other ~70% resides within the exchangeable pool (Figure
9C). In the IDR only, FMRP shifts significantly into the exchangeable pool. The mobile
fraction for IDR (86.4%) is significantly larger than WT and adding the KH domains back
does not increase core occupancy (86.5%) (Figure 9C). Interestingly, the immobile fraction
is completely absent in ∆IDR (Figure 9C). These data suggest that the ∆IDR granules that
form are completely lacking the stable core associated with WT-FMRP granules.
In addition to a large immobile pool, the mobile fractions within WT granules have
a relatively slow recovery time (recovery half-time or t1/2= 12.1s; Figure 9D). The IDR and
∆IDR formed granules that shared ~ 10-fold more rapid exchange rates (t1/2= 1.7s and 1.6s,
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respectively). KH+IDR significantly increased recovery time (t1/2= 3.6s) relative to the IDR
and ∆IDR, suggesting the KH domains are contributing some stability to interactions
within the dynamic shell of FMRP granules. Altogether, these data support the hypothesis
that the IDR and KH domains are collectively contributing to granule stability.
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Figure 9. Loss of the IDR abolishes the immobile fraction of FMRP granules
Representative time-lapse images of FMRP-mutant FRAP pre-bleach and at 1, 3 and 15
seconds following the bleaching event. Scale bar in whole cell image: 5µm. Scale bar in
zoomed in granule image: 0.5µm. Images show differences in recovery rates in the first 15
seconds of recovery. (B) Nonlinear one-phase association curves of FRAP experiments
representing fluorescence intensity of granules relative to initial intensity over 120 seconds
(mean ± SE; n=17-23 granules). Figure legend on the bottom indicate the different mutants.
(C) Comparison of the average mobile fraction of FMRP mutant granules. Average mobile
fraction for genotype is annotated at the top of each bar (mean ± SE; n=17-23 granules).
a.u.=arbitrary units. (D) Quantification of the average time for granules to recover half their
mobile fraction, or final intensity in seconds. Average t1/2 is annotated at the top of each
bar (n=17-23 granules). Statistical analyses were done by Brown-Forsyth ANOVA
followed by Dunnett’s T3 multiple comparisons test.
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We next wanted to determine how the KH point mutants affected FMRP granule
dynamics,

predicting

that

they
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contribute
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FMRP

exchange

rates.

To test this, we analyzed dynamics of the KH1* and KH2* mutants in S2 cells using FRAP.
Mutating either or both of the KH domains caused FMRP granules to recover much more
rapidly than WT, similar to the IDR and ∆IDR mutants (Figure 10A-B). Notably, ∆KH had
the opposite effect and significantly reduced exchange rates of the mobile pool, similar to
what has been previously shown (Figure 10B; Gareau, Martel, et al. 2013). The immobile
fractions of KH1* and KH2* FMRP granules were no different from WT, whereas *KH2*
reduced the exchangeable pool roughly 15%, similar to ∆KH (Figure 10C). This suggests
that disruption or deletion of both KH domains severely disrupts FMRP granule dynamic,
potentially in a non-physiological manner. As expected, KH1* and KH2* impacted the rate
of recovery of the dynamic shell which recovered much more rapidly (t1/2= 4.3 and 13.1s
for KH1* and KH2*, respectively), than WT (t1/2= 21.9s; Figure 10D). This supports our
previous findings that the KH domains function in stabilizing homotypic or heterotypic
interactions between FMRP and constituents of the mobile fraction of granules. As with
granule formation (Figure 7C), the effects of the KH1* and KH2* mutations do not appear
to be additive, as KH1*KH2* represents an intermediate between the individual mutations
(Figure 10D). Collectively, these data are consistent with the model suggesting
multivalency is the driving force underlying granule formation and that reducing valency
of FMRP increases dynamics by destabilizing overall protein interaction strength (Shin and
Brangwynne, 2017). Most notably, we provide evidence showing that not all interaction
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domains are created equal in FMRP, and the KH1 and IDR are more essential for this
process.
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Figure 10. FXS-causing point mutants increase the exchange rate of mobile fraction
in FMRP granules
(A) Representative time-lapse FRAP images showing differences in recovery rates
between WT, FXS-causing point mutations and ∆KH up to 20 seconds following the
photobleaching event. Scale bar in whole cell: 5µm. Scale bar in zoomed-in granule image:
0.5µm. (B) Nonlinear one-phase association regression recovery curves of FMRP-mutants
representing fluorescence intensity of granules relative to initial intensity over 120 seconds
(mean ± SE; n=17-21 granules). (C) Average mobile fraction of FMRP mutant granules
(mean ± SE; n=17-21 granules). a.u.=arbitrary units. (D) Quantification of the average time
in log (seconds), it takes for granules to recover half of their exchangeable pool. Average
t1/2 is annotated at the top of each bar (n=17-21 granules). Statistical analyses were done
by (C) Brown-Forsyth ANOVA followed by Dunnett’s T3 multiple comparisons test.
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2.4 FXS-causing mutations alter the liquid-like nature of stress granules
FMRP is a constituent of several different RNP populations in cells including Pbodies and SGs (Kapeli and Yeo, 2012; Sossin and DesGroseillers, 2006). As we show
above that the KH domains regulate FMRP granule formation and dynamics, we were
curious whether the disease-causing mutations in the KH domains had an effect on the
interaction of FMRP with these RNP populations or on their formation.
To examine interactions with SGs, we co-transfected S2 cells with EGFP:FMRP
constructs and mCherry-tagged Rasputin (Rin), the fly ortholog of G3BP1, a highly
conserved SG marker (Yang et al., 2020). First, we were interested in whether KH1* and
KH2* induced SG formation prior to the introduction of a stressful stimuli. We found that
a subset of cells formed SGs prior to the introduction of a stressor in all cases, which is
likely the result of Rin overexpression, which is known to induce SG formation (Matsuki
et al., 2013) (Figure 11A-B). Strikingly, we noticed that all cells forming KH1* granules
significantly overlapped with the population of cells forming SGs (Figure 11A). While
each of the FMRP constructs usually overlapped with the Rin granules, KH1* granules
only formed when Rin granules were also present. Due to diffuse cytoplasmic staining in
unstressed cells overlapping with punctate granules, quantifying this was not possible (data
not shown). This suggests that KH1* preferentially localizes to pre-formed SGs and is
likely dysfunctional in its ability to assemble granules on its own.
To see if these mutants altered the liquid-like properties of SGs that formed in
unstressed cells, we quantified the number of cells that formed Rin-positive SGs after
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treatment with 1,6-hexanediol (Figure 11B). 1,6-hexanediol is an aliphatic alcohol that
disrupts weak hydrophobic protein-protein (π-π) and protein-RNA (π-cation) interactions
required to form dynamic MLOs (Itoh et al., 2021; Kroschwald et al., 2015, 2017).
Overexpressing Rin and FMRP induced SG formation in approximately 20% of transfected
cells and similar results were observed with KH1*, KH2*, KH1*KH2*, and ΔKH (Figure
11B, left). Interestingly, the population of Rin-positive granules observed in these cells did
not disappear after treatment with 1,6-hexanediol, suggesting these non-stress-induced SGs
are less liquid-like in nature, and may be forming stable structures (Figure 11B, right).
Although this may be indicative of the overexpression of Rin or the FMRP constructs as
causing aggregate formation in a small subset of cells which could be toxic, it’s likely to
be mild as these cells showed no significant defects in viability (Figure 11D).
To gain further insight into the biophysical properties of FMRP granules, we treated
co-transfected cells with 1,6-hexanediol and looked at the impact on FMRP (Figure 11C).
As expected WT, KH1* and KH2* mutant FMRP granules readily dissociated upon
treatment, suggesting that they are forming liquid-like assemblies in S2 cells (Figure 11Cright). However, ΔKH and KH1*KH2*, do not show as robust of a response to 1,6hexanediol implying that these are forming granules with solid-like characteristics. These
results support our FRAP data and indicate that ∆KH, and to a lesser extent KH1*KH2*,
is inducing the formation of non-physiological solid-like aggregates in cells and are not
behaving similarly to the single missense mutations.

55

A.

B.

C.

D.

Figure 11. KH1* is only capable of interacting with pre-existing Rin+ SGs
(A) Representative images of the intracellular localization of transiently transfected FMRP
mutants (green) and Rin (magenta). Constructs shown are indicated in the top left corner
of each image. FMRP and Rin merged images are shown in the right column. White
arrowheads point to colocalized FMRP and Rin granules which only occurred in KH1*.
Scale bar: 2µm. Comparison of the percent of co-transfected cells forming (B) Ringranules or (C) FMRP granules without (left) or with (right) the addition of 10% 1,6hexanediol. Cells were incubated with 1,6-hexanediol or with media (no treatment) for up
to 20 minutes to count the number of cells forming granules. Approximately 100 cells were
manually analyzed in triplicate for each genotype per treatment group and compared to WT
(mean ± SE). (D) Trypan Blue stain was used to determine percent viability of cells
ectopically expressing each of the FMRP-mutants in triplicate (mean ± SE). Statistical
analyses were done by (B-C) ordinary two-way ANOVA followed by a Šídák's multiple
comparisons test and (C) ordinary one-way ANOVA followed by Holm-Šídák's multiple
comparisons test.
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FMRP is a core component of SGs and has been shown to readily shift into SGs
following stress induction (Gareau et al., 2013a). As expected, under arsenite-induced
stress, we see that most of the FMRP and Rin proteins shift out the cytoplasm and sink into
granules (Figure 12A). Rin almost always overlapped with WT, KH1*, KH2*, and
KH1*KH2* while ∆KH modestly reduced this colocalization (Figure 12B). These data
suggest the KH domains are not required for FMRP localization to SGs. However, cotransfection with KH1* or KH2* modestly but significantly reduced arsenite-induced SG
formation (Figure 12C, left). Moreover, dissolution of these SGs following 1,6-hexanediol
treatment was significantly reduced in these mutants, revealing that the KH mutations are
shifting these SGs from liquid-like to more solid structures (Figure 12C, right). Together,
these data suggest that SG dynamics are significantly impacted by these FXS-causing point
mutations.
We next asked whether these mutations altered how FMRP associated with
arsenite-induced SGs. Although stress is not required to induce the formation of FMRP
granules, it shifts FMRP from the cytoplasm, polyribosomes, or other RNPs into SGs
(Gareau et al., 2013a). Interestingly, fewer cells expressing KH1* and KH1*KH2* formed
FMRP granules in response to arsenite stress compared to WT (Figure 12D, left). This is
consistent with the reduced ability of KH1* to form granules in unstressed cells. As with
Rin-positive granules, FMRP granules in stressed cells did not dissolve as readily when
treated with 1,6-hexanadiol suggesting that they are forming solid-like structures (Figure
12D, right). KH1*, KH1*KH2*, and ∆KH granules most notably only mildly dissolved
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following the addition of 1,6-hexanediol (Figure 12D). This further implicates the KH
domains in initiating the transition from a liquid to a solid-like assembly, particularly in
the case of ∆KH granules. Altogether, these data show that while the KH domains are not
required for SG formation or FMRP recruitment to SGs, they contribute important dynamic
interactions within these structures, as mutating either or both KH domains causes both
SGs and FMRP granules to transition from dynamic liquid-condensates to more stable
solid-like structures.
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Figure 12. Loss of either KH domain shifts causes the formation of solid-like granules
in arsenite stressed cells
(A) Representative images of the intracellular localization of transiently transfected FMRP
mutants (green) and Rin (magenta) treated with 0.5mM sodium arsenite for 45 minutes.
Constructs shown are indicated in the top left corner of each image. FMRP and Rin merged
images are shown in the right column. Scale bar: 2µm. (B) Comparison of the average
Pearson correlation coefficient between FMRP-mutants and the stress granule marker, Rin,
in arsenite treated cells (mean ± SE; n=8-10 cells). Comparison of the percent of transfected
cells treated with 0.5 mM sodium meta-arsenite for 45 minutes forming (C) Rin-granules
or (D) FMRP granules with or without 10% 1,6-hexanediol treatment. Approximately 100
cells were manually analyzed in triplicate for each genotype per treatment group and
compared to WT. (mean ± SE). Statistical analysis was done by (B) ordinary BrownForsyth ANOVA followed by a Dunnett’s T3 multiple comparisons test and (C & D)
ordinary two-way ANOVA followed by a Dunnett’s multiple comparisons test.
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2.5 The KH1 domain is essential for FMRP localization to P-bodies
In addition to SGs, FMRP has been shown to associate with P-bodies in fly and
mammalian neurons (Barbee et al., 2006; Cougot et al., 2008). Thus, we were next
interested in whether the KH mutants affected P-body assembly or colocalization. To
address this question, we used HPat, a highly conserved P-body component in yeast and
flies, as our P-body marker (Pilkington and Parker, 2008). HPat-positive P-bodies formed
in each of the mutants constitutively, suggesting that the KH domains are not required for
P-body assembly (Figure 13A). As expected, we found that some P-bodies did not have
any FMRP present within them (white arrowheads in Figure 13A and Figure 13B),
although most punctate FMRP colocalized with punctate HPat (Figure 13C). As FMRP is
not present in all P-bodies, this suggests that it is not required for P-body
assembly. Interestingly, we never saw KH1* granules overlapping with HPat granules,
implying that the KH1 domain may be required for FMRP recruitment to P-bodies (yellow
arrows in Figure 13A). Indeed, quantification of the average Pearson’s colocalization
coefficient shows a significant reduction in KH1* when compared with WT (Figure 13B).
It must me noted that, although the Pearson’s coefficient for KH1* is positive (which would
suggest an interaction between these proteins), this may be biased as this analysis does not
differentiate between diffuse FMRP and HPat fluorescence within the cytoplasm and
granules. Alternatively, reduced colocalization could be due to the lower number of FMRP
granules observed in the KH1* mutant (Figure 8D). In contrast, KH1*KH2* and ΔKH led
to the formation of large spherical granules that colocalized more strongly with HPat
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(Figure 13C), suggesting that FMRP and HPat may be sinking into these larger solid-like
structures. Collectively, we found that the KH1 domain is important for FMRP association
with P-bodies and disrupting this domain may be abolishing the transference of FMRP
from other granules such as SGs, into P-bodies.
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Figure 13. The KH1 domain is required for P-body association
(A) Representative images of the intracellular localization of transiently transfected FMRP
(green) and HPat (magenta). Arrowheads show HPat-positive granules that do not overlap
with an FMRP-positive granule. Arrows indicate KH1 induced stress granules that do not
overlap with P-bodies. Scale bar: 2µm. (B) Quantification of the average Pearson
correlation coefficient between FMRP-mutants and the P-body component, HPat,
compared to WT (mean ± SE of 12-13 cells). (C) Average Mander’s coefficient showing
the fraction of FMRP overlapping with HPat fluorescence. Statistical analyses were done
by ordinary one-way ANOVA followed by a Holm-Šídák's multiple comparison test.
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CHAPTER THREE: THE FMRP KH DOMAINS ARE REQUIRED FOR THE
FORMATION AND STABILIZATION OF NEURONAL GRANULES IN MOTOR
NEURONS

3.1 The KH1 domain is required for NG formation in primary motor neurons
FMRP plays a critical role in neurodevelopment by assembling into neuronal RNA
transport granules (NGs). These granules are important for the transport of FMRP,
translation machinery and specific mRNA cargo important for synaptic growth and
maintenance from the soma into distal neuronal processes (Antar et al., 2004, 2005, 2006;
Davidovic et al., 2007; Dictenberg et al., 2008; El Fatimy et al., 2016). FXS is caused by
loss-of-function of FMRP within neurons and presumably the subsequent loss of transport
and translation repression within NGs and at synapses. Patients with missense mutations
in the KH1 and KH2 domains present with severe FXS-phenotypes. Based on this, we were
next interested in exploring whether either of the KH domains played a role in assembly or
function of FMRP-containing NGs. Here, we took advantage of an established system
used to examine NG composition and dynamics in primary cultures of Drosophila larval
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motor neurons (Barbee et al., 2006). To study FMRP granules in vivo, we generated a series
of transgenic flies that allowed for their inducible expression under control of the
UAS/Gal4 system (Brand and Perrimon, 1993). To normalize expression levels, all
transgenes were inserted into the same locus on the 3rd chromosome near the endogenous
dFMR1 gene. All were also recombined with the FMR1∆50 null allele to reduce levels of
endogenous protein. Unless otherwise noted, experiments were done in a heterozygous null
mutant background (FMR1∆50/+). We drove the expression of our EGFP-tagged FMRP
mutants using a restrictive motor neuron-specific Gal4 driver (C380-Gal4, cha-Gal80).
Primary motor neurons were harvested from 3rd instar larva in order to study FMRP granule
formation and dynamics in vivo (hereafter referred to as WT,∆50/+, KH1*,∆50/+, etc.).
We first asked whether these mutants were capable of forming somatic and neuritic
NGs in primary motor neurons. Similar to what we saw in S2 cells, WT,∆50/+ and
KH2*,∆50/+ formed numerous round granules within the cell body (Figure 14A). In
contrast, KH1*,∆50/+ and KH1*KH2*,∆50/+ fluorescence was almost entirely diffuse and
cytoplasmic, with few or no granules forming within the soma or neurites. While we
observed only a slight reduction in the number of KH2*,∆50/+ MNs containing NGs,
KH1*,∆50/+ and KH1*KH2*,∆50/+ only formed NGs in ~2% and 10% of neurons,
respectively (Figure 14B) This is not likely to be due to reduction in protein expression in
either KH1* or KH1*KH2* as expression levels are similar among all constructs (Figure
14C). As with S2 cells, this signifies that the KH1 domain is essential for NG assembly
within neurons. The FMR1∆50/∆113 null background is viable through adulthood (Bushey
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et al., 2009). Ectopically expressing these mutants in the FMR1 loss-of-function, instead
of the FMR1 heterozygous background would be ideal in order to eliminate all endogenous
FMRP protein. However, expression of KH1* and KH1*KH2* causes embryonic lethality
when expressed in the FMR1∆50/∆113 background (data not shown). Notably, lethality
occurs even when expression of the mutants is driven by the restrictive motor neuronspecific driver, C380-Gal4,cha-Gal80. This suggests that the KH1* mutation may have
some unknown dominant-negative effect, particularly within motor neurons.
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Figure 14. The KH1 domain is essential for NG formation in motor neurons
(A) Representative Z-projections of major granule phenotype in Drosophila primary motor
neuron cell bodies. C380-cha-Gal80 was used to drive expression of the EGFP: FMRP
constructs (green) in a subset of primary motor neurons in the FMR1∆50/+ heterozygous
background. Scale bar: 2µm. (B) Comparison of the percent of EGFP-expressing motor
neurons forming granules in FMR1-heterozygous background. Mean percentage is shown
above respective bar (mean ± SE; n=20 cells in triplicate). (C) Western blot analysis of
EGFP (top) and FMR1 (middle) expression of UAS-EGFP and UAS-EGFP-FMRP
mutants under the C380-Gal4, cha-Gal80 selective motor neuron driver in the larval CNS.
a-tubulin was used as a loading control. Statistical analysis was done by ordinary one-way
ANOVA followed by a Holm-Šídák's multiple comparison test.
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3.2 The KH2 domain stabilizes the dynamic shell of NGs
Thus far, we have shown that the KH1 and KH2 domains, although similar in
predicted function, have substantially different effects on NG phenotypes. Abrogation of
NGs due to the KH1* mutation coincides with embryonic lethality in FMR1 nulls. The
KH1 domain therefore appears to be contributing some essential function which correlates
with NG formation. KH2*,∆50/+ on the other hand, only mildly disrupts NG formation
and has no negative impact fly viability. As we have previously shown that the point
mutants disrupt granule dynamics in S2 cells, we were curious whether KH2* similarly
impacted NGs.
We predicted that NGs are more stable within neurites than in the soma which could
prevent the loss of granule constituents during active transport. To determine whether there
was a difference between these populations, we photobleached individual round granules
in either the soma (top panel-Figure 15A) or neurite (top panel-Figure 15B) and compared
recoveries over a 3-minute span. Extending FRAP analysis beyond 200s was not possible
due to excessive photobleaching (data not shown). Contrary to what we predicted, there
was not an increased immobile fraction of WT granules in the soma vs. neurites (black
bars-Figure 15E). Instead, we saw a the mobile fraction in neurites recovered two times
slower than in somatic granules (black bars-Figure 15F). This suggests that, while WT
FMRP is not reorganizing into stable “cores” within neuritic NGs, FMRP within the
dynamic shell is instead forming more stable interactions which is maintaining NG
structure during transport.
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We next compared the recovery curves of somatic and neuritic populations of
KH2*,∆50/+ NGs to determine whether the KH2* mutation disrupted stability. Somatic
and neuritic recovery curves for WT,∆50/+ and KH2*,∆50/+ were quite similar, although
KH2*,∆50/+ mobile fractions recovered much more rapidly than WT,∆50/+ in both the
soma (Figure 15C) and neurites (Figure 15D). Interestingly, we observed dramatic
alterations to both the mobile and immobile pools of KH2*,∆50/+ NGs. In contrast to WT
granules, we saw a significant shift of KH2*,∆50/+ into the immobile fraction in both NG
populations (immobile fraction increased by 5.6% ± 1.19 in soma and 12.9% ± 1.06 in
neurites; Figure 15E). Strikingly, mobile fractions of KH2*,∆50/+ NGs recovered ~7 times
more rapidly than WT,∆50/+ in soma and ~15 times more rapidly in neurites (Figure 15F).
This highlights the importance of the KH2 domain in contributing stabilizing interactions
within the dynamic shell of NGs. Altogether, these data suggest that the KH2 domain
moderates NG granule shell/core organization by 1) causing more KH2* to shift into the
nondynamic core and 2) destabilizing the remaining KH2* in the shell.
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Figure 15. The KH2 domain stabilizes NG interactions
(A) Representative time lapse images of somatic FRAP NGs pre-bleach, 1 second postbleach and then at 10, 25, and 200 seconds following the bleaching event. Scale bar in
whole cell image is 2 µm. Scale bar in zoomed-in granule image is 1 µm. (B)
Representative time-lapse images of neuritic FRAP NGs pre-bleach, 1 second post-bleach
and then at 10, 25, and 200 seconds following the bleaching event. Neurites are outlined in
green in the pre-bleach image, arrow heads point to the photobleached granule. Scale bar:
1µm. Nonlinear one-phase association regression curves of NGs representing fluorescence
intensity of (C) somatic NGs and (D) neuritic NGs relative to initial intensity over 200
seconds (mean ± SE; n ≥ 9 granules). (E) Comparison of the average mobile fractions of
somatic and neuritic mobile fraction of WT and KH2* NGs (mean ± SE; n ≥ 9 granules).
a.u.=arbitrary units. (F) Comparison of the average fluorescence recovery half-time of
somatic and neuritic mobile fraction of WT and KH2* NGs (mean; n ≥ 9 granules).
Statistical analysis was done by ordinary two-way ANOVA followed by Šídák's multiple
comparison test.
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3.3 The KH2 domain is important for neuritic transport
We were next curious as to whether biophysical alterations observed in
KH2*,∆50/+ NGs, had any impact on NG transport as this could impact FMRP function
and mRNA trafficking out to the synapse. We noticed conspicuous differences in NG
number and distribution between WT,∆50/+ and KH2*,∆50/+ in neurites (Figure 16A).
Although we previously saw minimal defects in KH2*,∆50/+ NG formation (Figure 14B),
we found 30% fewer granules out in neurites when compared with WT,∆50/+ (11.2 ± 3.30
fewer granules in KH2*,∆50/+; Figure 16B). Although, it is possible that this simply due
to a reduction in the number of granules in neurons this is potentially indicative of transport
defects in these mutant granules. To determine whether this was true we calculated the
percentage of granules in neurites proximal (<10µm) and distal (≥10µm) from the soma.
We found a significant reduction in the proportion of neuritic KH2*,∆50/+NGs in distal
neurites, further supporting that this mutation results in NG transport defects (Figure 16C).
We next asked whether KH2*,∆50/+ displayed altered neuritic transport of NGs.
Similar to what others have found, the majority of WT,∆50/+ NGs were static with ~20%
actively transported through neurites (Kao et al. 2010; Cioni et al. 2019; Figure 16D).
KH2* had no impact on directionality of NG transport (X2 = 0.581, p= 0.748; data not
shown). However, KH2* did impact the kinetics of NGs. We observed a significant
increase in the anterograde velocity KH2*,∆50/+ granules (Figure 16E). Increased
velocities would be expected to increase shear force on liquid droplets caused by
hydrodynamic drag which could account for the reduction of observable KH2*,∆50/+
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granules out in distal neurites. Additionally, this increased velocity could also reduce NG
docking to synaptic compartments, preventing granules and their constituents from
entering synapses, although this typically results in an accumulation of granules out in
neurites which we did not see with KH2*,∆50/+ (Kao et al., 2010; Yoshimura et al., 2006).
Altogether these data suggest that the KH2* mutation is disrupting FMRP granule transport
out towards distal regions of neurites.
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Figure 16. KH2 domain is necessary for NG transport into neurites
(A) Representative images of FMRP, FMR1∆50/+ (left) and KH2*, FMR1∆50/+ (right)
primary MNs. WT and KH2* GFP granules can be visualized in the soma (cell body) and
neurites (branching off of cell body). Scale bars: 10µm. (B) Box and whisker plot
comparing the average total number (box) of NGs within neurites of primary MNs. Range
of neuritic granule number is represented by dots. (mean ± SE; n=17-18 MNs). (C) Box
and whisker plot showing the average (box) percentage of neuritic granules that are distal
(≥10 µm) from the motor neuron cell body. Range of distances is represented by dots.
(mean ± SE; n=17-18 MNs). (D) Pie charts representing fraction of neuritic granules that
remain stationary (static) or move in the anterograde or retrograde direction (relative to the
cell body). Percentages are annotated in the legends. Total number of granules counted in
17 MNs are indicated within each pie chart. (E) Comparison of anterograde and retrograde
velocities of motile FMRP, FMR1∆50/+ and KH2*, FMR1∆50/+ neuritic NGs (mean ±
SE; n=46-75 granules per category). Statistical analyses were done using unpaired t tests.
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CHAPTER FOUR: FUNCTIONAL IMPACTS OF FXS-CAUSING POINT
MUTATIONS ON FMRP IN DROSOPHILA MELANOGASTER

4.1 The KH1 domain is required for FMRP-mediated translational repression
FMRP has been shown to interact with about 4% of neuronal mRNAs, although the
mechanism by which it is able to bind and regulate such a large subset of mRNAs is still
unclear (Ashley et al., 1993; Brown et al., 2001). Recent evidence suggests that the RGG
box of mammalian FMRP contributes target specificity by binding to G-quadruplex
structures in mRNAs and that these interactions are important regulating mRNA neuritic
transport (Goering et al., 2020). In contrast, the KH domains which bind to short,
ubiquitous sequences, are important for polysome association and are implicated in
suppressing translation elongation via ribosome stalling in flies (Chen et al., 2014; Darnell
et al., 2005; Feng et al., 1997). Previous studies show that KH1* is defective in binding
three

known

mRNA

targets

CaMKII,

PSD95,

and

Map1B

using

RNA-

coimmunoprecipitation followed by qPCR in mouse cortical neurons (Myrick et al., 2014).
However, loss of binding does not directly indicate that KH1* is non-functional in
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translation repression. In contrast, KH2* which has been better characterized, disrupts both
RNA-binding and translation repression of several known FMRP targets (Ascano et al.,
2012; Darnell et al., 2005; Siomi et al., 1994).
To determine the role of the KH domains in regulating translation in S2 cells, we
examined the ability of these FXS-causing mutations to repress translation in a modified
λN-based tethering assay (Rehwinkel et al., 2005). In this set of experiments, λN-FMRP
was artificially tethered to the 5X BoxB sequence in the 3’UTR of the luciferase reporter
(Figure 17A). This allowed us to study translation repression of each of the FMRP mutants
in an mRNA-binding independent manner. In λN-FMRP we see repression of the firefly
luciferase (FLuc) reporter, indicating that λN-FMRP is able to inhibit translation when
tethered to a transcript in the 3’UTR (Figure 17B). Interestingly, λN-KH2* was similarly
able to repress reporter translation, which was surprising given that the KH2 domain is
expected to repress translation by interacting with the elongating ribosome (Darnell et al.,
2011). In contrast, significant de-repression was observed with the λN-KH1* and λNKH1*KH2* mutants (Figure 17B). This suggests that the KH1 domain is important for
translation inhibition, consistent with published data (Chen et al., 2014).
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Figure 17. The KH1 domain is required for FMRP-mediated translational repression
(A) Diagram of the FLuc reporter fused to a 5xBoxB 3’UTR. Luciferase assays of (B)
λN:HA-tethered FMRP-mutants repression of the 5xBoxB FLuc reporter FLuc/RLuc
ratios were normalized to empty vector ratios. Graph shows repression of the FLuc reporter
by empty vector or FXS-causing point mutants compared to pAc5.1-FMRP (mean ± SE).
Statistical analysis was done by ordinary one-way ANOVA followed by a Holm-Šídák's
multiple comparison test.

77

4.2 The KH domains are required to regulate translation of known target mRNAs
Next, we were interested in addressing whether untethered FMRP could repress the
translation of the FLuc reporter by binding to the 3’UTRs of known mRNA targets of
FMRP and whether the KH domains were required for this to occur (Figure 18A). To test
this, we cloned the 3’UTR of camkii, FMR1, the degenerin/epithelial sodium channel
(DEG/ENaC) family protein, pickpocket (ppk), and the gene encoding the Drosophila
homolog of the actin-binding protein profilin, chickadee (chic) into the FLuc reporter
vector replacing the BoxB 3’UTR (Hou et al., 2006; Reeve et al., 2005; Rehwinkel et al.,
2005; Schaeffer et al., 2001; Xu et al., 2004). It is not known precisely how FMRP binds
to these targets although FMR1 and chic are predicted to contain G-quadruplexes (Kikin et
al., 2006). Similar to the 5X BoxB assay, KH2* did not disrupt repression of the ppk,
FMR1, and chic luciferase reporters, suggesting that the KH2 domain may not be required
for translational repression of these specific reporter mRNAs (Figure 18B-D). In contrast,
we saw significant de-repression with KH1* and KH1*KH2*, implying that the KH1
domain is required for translation repression of this subset of reporters. Interestingly, the
KH1 domain appears to be dispensable for repression of the camkii reporter, while KH2*
slightly, but significantly de-represses translation (Figure 18E). These data suggest that the
individual KH domains regulate the translation of distinct mRNA populations and supports
previous work that these domains are important for FMRP function in translation
regulation. Importantly, the loss of repression in KH1* correlates with the failure to form
FMRP granules.
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Figure 18. The KH domains regulate translation of different mRNA targets
(A) Diagram of the FLuc reporters used in this study fused to the 3’UTR of certain known
targets of FMRP. Luciferase assays comparing repression of FLuc fused with (B)
pickpocket (ppk) 3’UTR, (C) chickadee (chic) 3’UTR, (D) fragile x mental retardation 1
(FMR1) 3’UTR or (E) calcium/calmodulin kinase ii (camkii) 3’UTR by untethered FMRP
mutants. FLuc/RLuc ratios were normalized to empty vector ratios. Graph shows
repression of the FLuc reporter by empty vector or FXS-causing point mutants compared
to pAc5.1-FMRP (mean ± SE). All statistical analyses were done by ordinary one-way
ANOVA followed by a Holm-Šídák's multiple comparison test.
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4.3 FMRP KH domains are important for modulating synapse formation
The Drosophila larval neuromuscular junction (NMJ) has been used extensively as
a model synapse to study FXS in flies. The fly NMJ contains a simple glutamatergic
synapse, resembling those found in the mammalian CNS and Drosophila FMRP has a wellestablished presynaptic function in the control of NMJ development (Drozd et al., 2018;
Zhang et al., 2001). To study how the FXS-causing KH mutations affect the function of
FMRP at this synapse, we analyzed the number of synaptic specializations or “boutons”
that formed at the larval NMJ of the well-characterized body wall muscles 6/7 in abdominal
segment 3 when FMRP was overexpressed using the motor neuron-specific driver, C380Gal4 (Figure 19A). This NMJ is innervated by two neurons which form type 1 “big” (1b)
and “small” (1s) motor neurons which can be easily distinguished from each other by size
and immunostaining. Synaptic boutons of these MNs are visualized using antibodies
against discs large, or DLG, which is the Drosophila ortholog of the post synaptic markers
PSD-95/SAP70 and the neuronal membrane marker, HRP (Lahey et al., 1994; Menon et
al., 2013). While 1b boutons are much larger in area and contain more DLG-containing
active zones in the juxtaposed postsynaptic space, 1s boutons are characterized by their
relatively small size and association with significantly fewer active zones.
FMRP negatively regulates synaptic growth in motor neurons and overexpression
of FMRP in the UAS-FMR1 fly has been shown in previous studies to significantly reduce
synaptic terminal growth at the larval NMJ (Zhang et al., 2001). Here we were able to
recapitulate the reduction of 1s (Figure 19B) and 1b (Figure 19C) boutons normalized to
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muscle area (µm) at the UAS-FMR1 NMJ (Zhang et al., 2001). We also saw a reduction in
synaptic complexity in these flies assayed by the number of “tips” of strings of boutons
(Figure 19D). Overexpression of EGFP-tagged FMRP (UAS-EGFP-FMRP) at the fly NMJ
only affected 1b boutons, in which we saw a reduction relative to our overexpression
control (UAS-EGFP) (Figure 19C). This indicated to us that our UAS-EGFP-FMRP
construct was functional within fly motor neurons. Interestingly, although overexpression
of UAS-EGFP-KH1*, UAS-EGFP-KH2*, and UAS-EGFP-KH1*KH2* had no effect on 1s
or 1b bouton numbers, each of these mutants reduced complexity of the NMJ (Figure 19D).
Taken together, this suggests that bouton number and arborization are not necessarily
linked processes. While the KH domains may be required to regulate RNAs involved in
bouton growth they may not be required to regulate RNAs involved in branching.
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Figure 19. FXS-causing point mutants disrupt FMRP function in synapse formation
(A) Wandering third instar larval NMJs from C380-Gal4/+;;UAS-EGFP/+ controls,
FMRP overexpression, UAS-FMR1 and UAS-EGFP-FMRP, and FXS-causing point
mutant overexpression, UAS-EGFP-KH1*, UAS-EGFP-KH2*, and UAS-EGFPKH1*KH2* in C380-Gal4 motor neurons. Maximum Z-projections of NMJs in abdominal
segment 3 innervating body wall muscles 6/7 were stained with antibodies targeting the
postsynaptic density marker DLG (green) and the neuronal membrane marker, HRP
(magenta) for analysis. Scale bar: 50µm. (B) 1s bouton number/muscle area (µm) and (C)
1b bouton number/muscle area (normalized to control were manually counted and
compared with the control NMJ (n ≥ 11 NMJs, mean ± SE). All statistical analysis was
done by Brown-Forsyth ANOVA followed by a Dunnett’s multiple comparison test.
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4.4 FXS-causing point mutants do not cause localization defects of a target mRNA
As previously stated, NGs are a specialized type of RNP granule within neurons
which function in transporting translationally arrested mRNAs between the cell body and
dendrites/axons (Kiebler and Bassell, 2006; Krichevsky and Kosik, 2001; Lai et al., 2020).
As the KH domains are essential in regulating distinct mechanisms involved forming
FMRP granules, we were interested in whether the loss or reduction of FMRP granules in
neurites, as seen with in KH1*,∆50/+ and KH2*,∆50/+, had any impact on the transport
of a known mRNA target. Using single molecule Fluorescence in situ hybridization
(smFISH) we were able to address this question by quantifying camkii transcripts in the
soma and neurites in our EGFP-FMRP, ∆50/+ primary motor neurons.
CamKII is a kinase critical for regulating synaptic plasticity and memory formation.
Its mRNA is spatially localized to both pre- and postsynaptic densities where it’s regulated
by FMRP (Kao et al., 2010; Zalfa et al., 2003). In fly primary motor neurons, FMRP has
been shown to colocalize with a MS2-tagged camkii RNA within FMRP granules (Estes et
al., 2008). Using smFISH we were able to detect single camkii transcripts throughout the
cell soma and out in neurites (Figure 20A). We did not include the KH1*KH2* double
mutant in these analysis as we do not believe this construct is physiologically relevant
(based data shown throughout Chapter 2). Interestingly, we found that all of the FMR1
mutants, including controls had significantly fewer transcripts in the soma compared with
the C380-Gal4,cha-Gal80 controls, suggesting that any reduction of endogenous FMRP
impacts total transcript number (Figure 20B). Interestingly, we found that there was a
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significantly higher percentage of camkii transcripts out in the neurites of WT,∆50/+ MNs
relative to the FMR1-nulls (Figure 20C). This suggests that FMRP can promote the
transport of camkii mRNA in neurites. Although the percentage of neuritic transcripts was
lower in the KH mutants compared to WT,∆50/+ MNs, the results were not statistically
significant. This indicates that the KH domains are not required to regulate transport.
Moreover, normal localization of camkii in KH1* suggests that FMRP granule formation
is not a prerequisite for transport. This cannot be explained by the presence of one copy of
FMRP in these experiments because ∆50/+ results are similar to ∆50/∆113. In summary,
these data indicate that FMRP can promote, but is not required for, camkii transport in
neurites. Moreover, neither of the KH domains are required to control this process.
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Figure 20. The KH domains are not required for camkii transport in MNs
(A) Representative images of camkii mRNA smFISH in MNs. Yellow arrowheads in
images are distinguishing camkii transcripts out in neurites. Scale bar: 10µm. (B)
Comparison of the average number of camkii transcripts in soma and (C) comparison of
the average percentage of camkii transcripts in neurites in C380-Gal4, cha-Gal80,
FMR1∆50/∆113 nulls, EGFP, FMR1∆50/+ control and each of the FMRP, FMR1∆50/+
mutants relative to the ∆50/∆113 control (mean ± SE of 11-20 MNs). Statistical analyses
were done using a (B) one-way ANOVA followed by the Holm-Šídák's multiple
comparisons test and (C) Kruskal-Wallis test followed by the Dunn’s multiple comparisons
test.
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CHAPTER FIVE: DISCUSSION
5.1 Multivalency drives FMRP granule formation in vivo
Here, we show that the IDR and KH domains cooperate with each other to promote
FMRP granule formation in vivo. Granule formation is driven by LLPS, a biophysical
process wherein densely packed molecules spontaneously form a membraneless
condensate upon reaching a critical concentration (Alberti, 2017). These condensates
loosely confine the proteins and RNAs required for a biological process to occur in a
particular space and time. This spatial and temporal regulation is important for diminishing
off-target interactions that could occur within the cytoplasmic environment. In the context
of RNA granules, these condensates can be important for removing particular mRNAs from
the cytoplasmic environment to reduce expenditure of energy on costly processes such as
translation during times when energy conservation is a priority (e.g. during stress).
IDRs have a high propensity to phase separate in vitro and are enriched in other
IDR-containing proteins, which has led to an overestimation of their function within
biological systems (Lin et al., 2015; Pechstein et al., 2020). A common misconception is
that the IDRs within phase separating proteins are the only domains contributing to these
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phase transitions. However, more studies are coming out and have illuminated weak,
multivalent interactions as the drivers of this process in vivo (Banjade and Rosen, 2014; Li
et al., 2012). Increased valency (i.e. more interaction domains) of a protein provides a
scaffold of cis-acting binding sites by which interactions with multiple protein or RNA
species can occur (Martin and Holehouse, 2020). These trans-acting binding partners are
then capable of interacting with more proteins or RNAs, enabling these biomolecules to
stack and concentrate within a small area (Banani et al., 2016; Li et al., 2012).
In our study we found that the FMRP IDR was alone capable of forming granules
in vivo although, it was able to do so in only ~65% of cells (Figure 6C). IDR-granules were
also quite different phenotypically from WT granules, suggesting that even though
granules are forming via this domain they are unlikely to be functioning properly (Figure
6B). These results indicate that the IDR is not the sole domain required for FMRP granule
formation and may function cooperatively with domains in the N-terminus to control this
process. This perhaps is not surprising as the other interaction domains within FMRP are
likely facilitating interactions with other core components of MLOs.
Further supporting this hypothesis, we found that adding back the KH1 and KH2
domains (KH+IDR) significantly increased granule formation in cells (Figure 6C). Perhaps
increasing the stability of interactions within these granules via increasing valency reduces
the critical concentration of FMRP needed to optimize phase separation. Further studies
could confirm this. As overall expression levels between these constructs were similar, we
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can conclude that the reduced propensities of mutants to form granules was not due to
lower protein concentrations, which could be influencing this process (Figure 6D).
In addition to affecting FMRP granule formation, the FMRP-IDR mutants
drastically altered its distribution within the cytoplasm. The IDR-mutants were
conspicuously much more diffuse within the cytoplasm further implicating the exclusion
of a large fraction of these mutants from granules. This exclusion is also likely to be caused
by reduced valency of FMRP. In support of this conclusion, we saw that when we increased
the number of interaction domains, granule occupancy increased and coincided with a
reduction in the cytoplasmic fluorescence intensity (Figure 6B & 8C). Altogether, we
found that the KH domains and IDR function cooperatively to promote FMRP granule
assembly (Figure 6-7). Our results thus support the model that multivalency is playing a
significant role in the ability of FMRP to form liquid-like granules in vivo.
5.2 The KH1 domain promotes FMRP granule formation in Drosophila
FXS is normally caused by a complete loss of FMRP expression. However unique
cases have occurred from single missense mutations within the KH domains, implying that
these domains are essential for normal FMRP function (De Boulle et al., 1993; Myrick et
al., 2014). KH1* was predicted to be a hypomorphic allele due to the loss of several major
FMRP-functions including polyribosome association and mRNA binding (Myrick et al.,
2014). Here, we show that KH1* also substantially diminishes FMRP granule assembly in
S2 cells (Figure 7C). This mutation also reduced SG-formation (Figure 12D) and FMRP
localization to P-bodies (Figure 13B). Even more striking, was the absence of KH1*
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granules in motor neurons (Figure 14A-B). Although we report KH1* granules in ~2% of
motor neurons, these cells were only able to form a single granule, suggesting that even in
the limited cases where granules are able to form, FMRP is not localizing normally (data
not shown). From this, we can infer that the KH1 domain promotes formation of SGs and
is essential for FMRP to form (or interact with) SGs, P-bodies, and NGs.
Interestingly, we found that in the FMR1 null mutant fly, KH1* and KH1*KH2*
caused embryonic lethality, even when expressed only in a subset of motor neurons (data
not shown). This was surprising, as loss of FMR1 expression in and of itself is not lethal.
This suggests that the KH1* mutation may have a quasi-dominant phenotype within motor
neurons which is causing lethality. We did not try expressing this mutant in other cell types
to see if this was a global phenomenon. Further studies looking into how KH1* increases
embryonic lethality will be important for gaining a better understand of how this domain
is disrupting FMRP function within neurons and how this mutation is causing FXS.
Our results beg the question: what’s so special about the KH1 domain? As we’ve
shown, valency and not individual interaction domains drive granule formation in vivo.
However, when we disrupt the KH1 domain by expressing the KH1* mutant, we see a loss
of FMRP-positive P-bodies and NGs. One explanation for the loss of KH1* granules is
that the KH1 domain could normally be increasing the valency of FMRP in granules by
binding ubiquitous sequence motifs in mRNAs, such as WGGA, nonspecifically (Ascano
et al., 2012). Arguing against this, the ACUK sequence, which is recognized by the KH2
domain is more highly enriched within the transcriptome than WGGA, specifically within
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genes linked with autism spectrum disorders (Ascano et al., 2012; Tran et al., 2019). If this
was the mechanism by which the KH1 domain affected granule formation, we would
predict that disrupting the KH2 domain would produce similar (or perhaps stronger)
defects. However, we do not see these same phenotypes in KH2* granules, suggesting this
may not be the mechanism by which KH1 contributes to granule formation.
Alternatively, KH1 domain interactions may be shifting the concentration threshold
required to promote FMRP granule formation (Figure 4B). Presumably, KH1 contributes
to granule formation by its associations with RREs in target mRNAs (Li et al., 2020). RNA
promotes LLPS of FMRP and other proteins such as hnRNPA1 and FUS, by shifting the
phase boundary and requiring lower protein concentrations to initiate phase separation
(Molliex et al., 2015; Schwartz et al., 2013; Tsang et al., 2019). Transcripts targeted by the
KH1 domain in particular may be recruiting FMRP to mRNPs, thereby bringing FMRP in
proximity with other protein/RNA species that it can then interact with via its other
interaction domains. However, the specific RNAs targeted by the KH1 domain remains
elusive. Future studies identifying the mRNAs targeted specifically by the KH1 domain
are needed to address this possible mechanism of granule formation. Additionally,
addressing whether these RNAs contain multivalent RREs are also needed to show if these
RNAs can seed granule formation more efficiently than other RNAs. Regardless of what
the particular mechanism is, our data unambiguously show that the interactions contributed
by the KH1 domain are essential for FMRP to form NGs and assemble to P-bodies.
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5.3 The KH2 domain stabilizes FMRP within granules, and loss of KH2 domain
function in the KH2* mutant disrupts NG dynamics and transport
The KH2 domain in FMRP is required for association with polyribosomes and stalls
translation elongation presumably through this association (Feng et al., 1997; Zang et al.,
2009). Here we show that translation repression and ribosome association via the KH2
domain are not required for granule assembly in vivo. In contrast, disruption of the KH2
domain has substantial impacts on the associative properties of FMRP within granules.
In S2 cells and primary MNs, we found that KH2* was destabilized within the
mobile fraction of granules, indicated by KH2* rapidly recovering after photobleaching
(Figure 10B). Protein valency is one of the mechanisms regulating mobile fraction
dynamics (Van Treeck and Parker, 2019). This is due to the increased propensity of a
protein with higher valency to come into contact with another binding partner before
exchanging. We believe that loss of KH2 domain function destabilizes the dynamic shell
of granules as a result of reduced valency, particularly because of the loss of a domain that
participates in binding to a highly prevalent RRE. The KH2 domain interacts with the short
sequence motif ACUK and loop-loop pseudoknot kissing complexes in transcripts (Ascano
et al., 2012; Darnell et al., 2005). ACUK is found ubiquitously throughout the
transcriptome (Suhl et al., 2014). It is therefore likely that KH2-ACUK interactions
increase FMRP valency by enabling FMRP to interact weakly with essentially any
transcript it comes into contact with. Although we did not test this hypothesis here, future
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studies looking at KH2* propensity to phase separate with different RNA species
containing varying numbers of ACUK sequences in vitro would be valuable.
While we saw destabilization of KH2* within mobile fractions, we simultaneously
observed a substantial shift of KH2* into the nondynamic core, particularly in neuritic NGs
(Figure 15C-F). Although a loss of valency could explain the increased exchange rate of
the mobile fraction, this does not explain why this mutation causes FMRP to shift into
stable cores. Immobile fractions are thought to be formed within granules via strong
intermolecular interactions, energy dependent processes or protein chaperones, and
posttranslational modifications (Banani et al., 2016; Jain et al., 2016; Van Treeck and
Parker, 2019). Mutations within granule-forming RBPs have a high propensity to
potentiate protein aggregation, which could account for what is occurring to KH2* in MNs.
Indeed, FMRP has a high propensity to aggregate in vitro, and in silico analyses have
identified multiple putative aggregation prone sequences within the FMRP CDS (Sjekloća
et al., 2009, 2011) Interestingly, one of these aggregation prone sequences occurs within
the KH2 domain, just outside of the RNA-binding pocket in which the KH2* mutation
occurs. Thus, the Ile307Asn mutation within this domain could potentially elevate
aggregation propensity by disrupting domain folding and increasing aggregation-sequence
site exposure.
In addition to altering the molecular dynamics of FMRP within granules, we found
that the KH2* mutation disrupted NG transport within neurites, in contrast to what has
been shown previously in rat PC12 cells (Castrén et al., 2001; Schrier et al., 2004).
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Interestingly, Schrier et al. found that the KH2 Ile304Asn mutation in human FMRP was
unable to form granules in PC12 cells, but was still able to localize out in neurites via
microtubules—potentially within sub-microscopic mRNPs (Schrier et al., 2004). However,
this lack of granule formation could be due to the relatively low expression level of their
Ile304Asn mutant in comparison to endogenous FMRP (i.e. mutant expression level was
reduced to half of endogenous FMRP). As granule formation is dependent on protein
concentration, this could explain the lack of observable granules in their study.
In agreement with previous literature, we provide evidence that the KH2* mutant
functions in, but is not required for neuritic transport of NGs (Schrier et al., 2004).
However, we did find that this mutation increased the kinetics of anterograde NGs (Figure
16E). Kinesins are a family of proteins that function as molecular motors for anterograde
transport and can mediate fast and slow transport, depending on the particular kinesin with
which the granule attaches (Arpag et al., 2014). Although the KH2 domain has not been
implicated in FMRP attachment to molecular motors, this mutation could potentially
enhance association of FMRP with adaptor proteins for different motors. These findings
may also explain why we see an overall reduction of KH2* granules in neurites,
particularly in distal neurites (Figure 16B-C). As destabilized KH2* granules are being
transported out in neurites more rapidly, we predict that these granules are falling apart
during transport. Future studies identifying which adapters and kinesin motors FMRP
attaches and how this is potentially disrupted in KH2* mutants will be important for
gaining a better understanding of NG transport kinetics.
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5.4 The KH domains are not required for camkii transport in motor neurons
We found that while FMRP promotes camkii transport in MNs, it was not required
for this process (Figure 17C). Moreover, we found that neither the loss nor disruption of
NG transport caused by KH1* and KH2*, respectively, had any effect on camkii transport
out in neurites. This coincides with a recent study implicating the requirement of the RGG
box, and not the KH2 domain of mammalian FMRP, for the localization of neuritic mRNAs
(Goering et al., 2020). Interestingly, RNA-seq analysis from their study determined that
translationally repressed transcripts did not overlap with transcripts dependent on FMRP
for their localization, suggesting an uncoupling of these two FMRP functions. However,
this may not be the case in flies. The fly RGG-box is only weakly conserved and has not
been shown to bind G-quadruplexes like the RGG-box in mammalian FMRP (Vasilyev et
al., 2015). Additionally, camkii is predicted to contain two weak G-quadruplex structures
throughout the entire transcript (Kikin et al., 2006). Perhaps camkii is being shuttled
through neurites via the IDR or other N-terminal interaction domains in this system.
Another surprising finding was the underwhelming degree of colocalization
between the camkii smFISH probes and FMRP (data not shown). There were only a few
instances of overlap that we saw between these molecules, which could indicate that camkii
may largely be transported via an FMRP-independent mechanism. Previous studies
showing FMRP colocalization with target transcripts in NGs, including camkii, have been
largely performed using the MS2-tagging system (Dictenberg et al., 2008; Estes et al.,
2008; Kao et al., 2010). Incorporating MS2-targeted stem loop structures into target
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mRNAs allows for transcript visualization when bound by MS2-GFP (Bertrand et al.,
1998). Our lab has shown that fly FMRP is capable of directly binding to MS2 stem loop
structures, which could explain why our results are in opposition to previous literature
using this system (Kaul et al., unpublished data).
Another explanation of the lack of camkii transcripts in FMRP granules could be
due probe inaccessibility in these RNPs. It has been previously shown that smFISH probe
hybridization is capable of being hindered for transcripts confined within tightly packaged
granules (Buxbaum et al., 2014). Thus, their occupancy within granules can effectively
“mask” the identification of these transcripts by blocking probe hybridization. We are
currently continuing our smFISH analysis with other transcripts predicted to be dependent
on FMRP granule transport to see if these findings are pervasive amongst multiple targets.
5.5 Granule formation may be a functional consequence of translational repression
Using tethered and untethered translation reporter assays we were able to determine
whether either of the KH domains were required for translation repression in an RNA
binding-dependent or independent manner. It’s predicted that the RGG box confers
specificity for mRNA targets by binding to higher-order structures within the CDS or
3’UTR in mammalian FMRP (Vasilyev et al., 2015). When bound to these transcripts via
the RGG box, the KH domains are then predicted to stall elongating ribosomes when they
come into proximity of FMRP (Harigaya and Parker, 2014). As RNAs are flexible
polymers, the KH domains could potentially stall translation by FMRP binding virtually
anywhere on the transcript. Many G-quadruplex structures in FMRP-targets are located in
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the 3’UTR, which was the reasoning behind the design of our luciferase reporters
containing putative RNA binding sites in the 3’UTR (Zhang et al., 2014). Using the QGRS
Mapper, we were able to identify putative G-quadruplex structures in the 3’UTRs of the
different FMRP target transcripts (Kikin et al., 2006). The FMR1 and chic 3’UTRs contain
G-quadruplex structures, which could be targeted by the RGG box. However, camkII and
ppk 3’UTRs are not predicted to contain these structures and thus are likely to either depend
on RGG binding to other RNA structures or on the other RNA binding domains within
FMRP.
In our study, we found that the KH1* mutant significantly impaired FMRPmediated translation repression of several FMRP targets (Figure 19). The KH1* mutation
disrupts mRNA binding and polysome association supporting our results (Myrick et al.,
2014). Our work here adds to these previous studies by showing that the KH1* mutation
can perturb translation repression independent of RNA-binding (Figure 18B). In contrast,
KH2* did not disrupt translation repression of most of the luciferase reporters used in this
study. This was surprising as the KH2 mutation has been shown to disrupt FMRP
translation repression in vitro (Laggerbauer et al., 2001). The KH1 domain, and to a lesser
extent the KH2 domain, inhibits ribosome translocation by directly binding the ribosome
(Chen et al., 2014). We argue that FMRP may function in translationally repressing our
luciferase reporters in a ribosome-binding and stalling-dependent manner, as we see a
greater effect when we disrupt the KH1 domain. It’s important to note that we were not
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able to distinguish whether the FXS-causing mutants were disrupting RNA-binding or
translation repression in our untethered luciferase reporter assays (Figure 19).
From these findings, we provide a model describing the functional consequence of
reduced granule formation by the KH1* mutation. Loss of RNA-binding, and thus valency,
through the KH1* mutation significantly destabilizes FMRP within granules. This
reduction in valency causes the phase transition boundary of these granules to shift upward,
requiring higher local FMRP concentrations to initiate this process. Loss of granules
indirectly reduces FMRP-mediated translation repression by reducing the propensity of
corralling particular interactors that may enhance repression. Although translation
repression is able to occur outside of granules, it is likely that within distinct cytoplasmic
foci all the required components are contained and primed for action. Thus, although loss
of granule formation does not abrogate this process, it can significantly inhibit it.
5.6 Disease-causing mutations in FMRP increase granule dynamics in contrast to
promoting the formation of pathological inclusions
Many proteins associated with neurodegenerative diseases including Alzheimer’s
disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) undergo phase
separation, linking MLOs to pathological inclusions which are a hallmark of these diseases
(Ryan and Fawzi, 2019). Neurons are particularly susceptible to the formation of these
pathological MLOs as they are post-mitotic cells that rely heavily on protein degradation
pathways which function less efficiently in aged neurons (Lim and Yue, 2015).
Interestingly we found in our study that FXS-causing point mutations in FMRP mostly
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form more dynamic condensates, in contrast to these solid aggregates. To our knowledge
this is the first time anyone has shown an MLO-associated protein linked to disease that
doesn’t have a propensity to form toxic insoluble aggregates when mutated.
What makes FMRP different from other phase separating proteins? Most other
proteins produce gain-of-function mutations that make them form more “sticky”
interactions within MLOs (Patel et al., 2015). This causes protein entrapment within
granules, incapable of exchanging with the surrounds environment and thus unable to carry
out normal functions. In the case of FMRP, we might be seeing the opposite effect. If
FMRP is unable to stabilize interactions between RNAs, translation machinery or other
RBPs within MLOs for long enough to carry out its normal function (in translational
repression or RNA transport) it may cause a significant reduction in function. Further work
needs to be done to determine whether altered dynamics of FMRP granules has a direct
effect on NG function. However, our study creates an interesting new framework for
understanding how disrupting stable interactions and multivalency effect granule
dynamics and formation and how some MLOs are more susceptible to these
perturbations.
5.7 Conclusions and future directions
FMRP is an important regulator of mRNA translation and transport within neurons.
It is enriched within multiple distinct cytoplasmic foci, in which it is predicted to regulate
these processes. Disruption of FMRP function due to single missense point mutations with
the RNA-binding KH domains produces severe FXS. Unraveling how these mutations alter
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FMRP-associated granules will aid in understanding what functions these domains have in
their interaction with particular MLOs and how this may impact their associated disease
states. The work presented here gives us a better understanding of the functions the
structured RNA-binding domains and IDR have in FMRP recruitment to FMRP granules,
SGs, P-bodies and NGs, and provides a model describing the functional consequence of
granule formation in the context of translation repression. Future studies looking the
differential interaction with the neuronal transcriptome in KH1* and KH2* are needed to
better understand which and how targets are regulated by these domains.
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CHAPTER SIX: MATERIALS AND METHODS
6.1 Experimental model and subject details
6.1.1 Fly stocks and husbandry
In all experiments, both male and female flies were used. Drosophila stocks were
incubated at 25°C with 12-hour light/dark cycles and 60% humidity on standard
Bloomington medium. Fly lines used and made in this study are listed in Appendix 1.
pUAST:attB:EGFP flies were generated via restriction cloning EGFP and each
EGFP-FMRP mutant into the multiple cloning site of pUAST-attB for directional cloning
into the 5’-KpnI and 3’-XbaI cloning sites. pUAST:attB:EGFP and pUAST:attB:EGFPFMRP mutants were sent to BestGene where these constructs were injected into fly strain
#24485 for PhiC31 integration into chromosome III. pUAST:attB:EGFP-FMRP mutant
flies were recombined with w1118;; FMR1Δ50M / TM6B, Tb+ FMR1 mutant flies for FMRP
primary motor neuron experiments. Final recombinants were genotyped for the FMR1∆50M
deletion by knocking out a single adult in a PCR tube on ice for 5 minutes. Flies were
squished with a 200 μL pipette tip in 5μL of squishing buffer (10 mM Tris-Cl pH 8.0, 1
mM EDTA, 25 mM NaCl, and 0.2 mg/mL proteinase K) and incubated at room temperature
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for 20 minutes. Samples were then boiled at 95°C for 5 minutes, cooled on ice for 3 minutes
and then spun down at 16,000X G for 5 minutes in benchtop centrifuge. For genotyping, 5
μL of the supernatant (genomic DNA prep) was used in a standard NEB One Taq
Polymerase PCR reaction using the FMR1deletion forward and reverse primers which were
annealed at 60°C and elongated for 7 minutes as described by Zhang et al. (Zhang et al.,
2001). PCR products were ran in a 1% agarose gel following standard DNA gel
electrophoresis procedures and probed for the presence of a 4.2 kbp (deletion) or 6.8 kbp
(wildtype) PCR product.
2.1.2 Schneider’s S2R+ and S2 cell culture
S2 and S2R+ cells were maintained at 24°C with ambient humidity in a dark
incubator and maintained on Shields and Sang M3 media (Sigma-Aldrich; S8398)
containing bactopeptone and yeast extract, and supplemented with 10% fetal bovine serum
(Gibco; 16000044), 1% penstrep (Invitrogen; 15070-063) and fungizone (Invitrogen;
15290-026), also known as M3+BPYE media. DNA transfections were performed with
Qiagen’s Effectene Transfection Reagent kit (Qiagen; 301425) (see below). Most
experiments were conducted on S2R+ cells due to their higher propensity to adhere to and
flatten out on cover slips, making imaging stationary cells more reliable.
6.1.3 Drosophila third-instar primary larval motor neuron tissue culture
Primary motor neurons were cultured from wandering 3rd instar larvae using a
tissue culture protocol adapted from Barbee et al. 2006. For each genotype, 10 larvae were
washed briefly in 70% ethanol, followed by five one-minute washes in 1xPBS pH 7.4.
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CNS’s were dissected from 3rd instar larvae in supplemented media, or M3+BPYE media
supplemented with 50 μg/mL insulin (Sigma-Aldrich; I6634), from which optic lobes were
also removed leaving only the ventral ganglia (VG). VG were washed briefly in
supplemented media five times, then transferred to a sterile microfuge tube containing ~1
mL of Rinaldini’s solution (800mg NaCl, 20mg KCl, 5mg NaH2PO4*H2O, 100mg
NaHCO3, 100mg glucose, and 1mL penstrep to final volume of 100 mL). VG were spun
for 5 minutes at 300 x G. Supernatant was carefully removed, and fresh Rinaldini’s solution
was added, vortexed, spun down and removed a total of five times to wash off residue yeast
and other contaminants. In a sterile hood, supernatant was removed and 1mL of Liberase
(Roche; LIBDH-RO; containing collagenase and dispase) supplemented Rinaldini solution
was incubated with VG for 1 hour. The dissociated tissue was then spun down for 5 minutes
at 300 x G. Supernatant was discarded and VG were washed another 4 times with
supplemented M3+BPYE media. Following this, the supernatant was removed and VG
were resuspended in 200µl of supplemented media. The dissociated VG were titrated with
a fire-polished, glass Pasteur pipette 56 times and then 175 times with a medium coated
P200 tip. The MN cell suspension was then seeded onto a single Concanavalin-A (SigmaAldrich; C2010) and Laminin (Corning; CB-40232) coated 35mm glass bottom dish
(Cellvis; D35-10-1-N). Once plated, cells were incubated at 24°C with ambient humidity
in a dark incubator 3-5 days before imaging. Media was carefully aspirated and replaced
every 2 days.

103

6.2 Method details
6.2.1 Molecular cloning and Site directed mutagenesis
For S2 cell fluorescence imaging, pAc5.1B:EGFP-FMRP-IDR and ∆KH mutants
were cloned into the multiple cloning site of pAc5.1B-EGFP following PCR amplification
of the target open reading frame(s) from pAc5.1B:EGFP-FMRP. Amplification primer
sequences and sites are listed and described in the Appendix 1. The human KH1 Gly266Glu
and KH2 Ile367Asn point mutations are orthologous to Drosophila Gly269Glu and
Ile307Asn, respectively. To generate these Fragile X Syndrome causing point mutants in
Drosophila FMRP, SDM primers were designed using the “substitution” feature in
NEBaseChanger v1.2.9 (New England BioLabs Inc.). Mutagenesis was designed to occur
at nucleotide 805-807 (GGA→ GAA) and nucleotide 868-870 (ATC→ AAC) in the KH1
and KH2 domain, respectively. NEB’s Q5 Site-Directed Mutagenesis Kit Protocol (E0554)
was conducted on the pAc5.1B:EGFP-FMRP vector to introduce the KH1 and KH2
missense mutations. The following modifications were made to NEB’s mutagenesis PCR
reaction: KH1 mutagenic primers Ta=62℃, elongation at 72℃ for 4 minutes; KH2
mutagenic primers Ta= 64℃, elongation at 72℃ for 4 minutes.
To clone the SG protein, Rasputin, into a C-terminally tagged mCherry vector, we
constructed a (Gly4Ser)3 linker-mcherry pAc5.1 vector. The mCherry-tag was amplified
from pAc5.1B-mCherry which included 5’-HindIII and 3’-BamHI restriction sites for
directional cloning into pAc5.1B with an in-frame stop codon following the mCherry
sequence. Primers for cloning the (Gly4Ser)3 linker upstream of mCherry were also
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designed to allow for ligation of the three fragments (pAc5.1 + (Gly4Ser)3 + mCherry) in
the correct orientation. To amplify Rasputin (Rin) to clone into the mCherry vector, total
RNA was extracted from four BL Canton S adult males using the Zymogen RNA extraction
kit and following the manufacturer's protocol (Zymo Research Corporation; R2060). RTPCR was then conducted on total RNA using Clontech’s RNA to cDNA EcoDry™ Premix
(Oligo dT) kit (#639543). Rasputin cDNA was amplified using primers that added 5’HindIII and 3’-EcoRI restriction sites for directional cloning into the mCherry vector to
make the final pAc5.1B:Rasputin-(Gly4Ser)3-mCherry.
The Fluc reporters used in the translation reporter assays were all sourced from the
pAc5.1C:FLuc:Stop:5BoxB backbone vector (Addgene #21301). The 5BoxB 3’UTR was
replaced with the 3’UTRs of FMR1 and camkii by Restriction or Gibson cloning
methods. We cloned the camkii isoform with the long 3’UTR, so that all possible binding
sites were conserved in the reporter. DNA from 4 adult male BL Canton S flies was
extracted and purified using the E.Z.N.A Tissue DNA kit (Omega Bio-Tek #D3396-01).
From the extracted DNA, the long 3’UTR of camkii was amplified using the
CaMKIIUTRFwdGA and CaMKIIUTRRvsGA primer set, then purified using Zymogen’s
DNA Clean and Concentrator-5 Kit (#11-302C). pAc5.1C:FLuc:Stop:5BoxB was digested
with EcoRI-HF and XhoI following NEB’s general protocol for restriction enzymes to
remove the 5xBoxB 3’UTR. The camkii 3’UTR was then cloned into the luciferase
destination vector via Gibson Assembly (#E2611) following NEB’s protocol. The FMR1
3’UTR was similarly amplified using the FMR1Fwd and FMR1Rvs primer set and then
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cloned into the pAc5.1C:FLuc:Stop:5BoxB destination vector using the 5’EcoRI and
3’XhoI restriction sites while removing the 5xBoxB sequence.
6.2.2 S2R+ and S2 cells transient transfections and cell viability assay
Transient transfections were performed following Qiagen’s standard Effectene
reagent protocol in which 0.5 μg of each construct was optimized, except for pAc5.1BEGFP:FMRP:KH1 in which 0.75 μg was transfected per 1 million cells in a 12-well plate.
Transfected cells were grown for approximately 72 hours before used in assays.
To determine whether any of the ectopically expressed FMRP mutants were lethal
to cells, we used trypan blue to identify differences in viability. Three days posttransfection, a 1:1 dilution was made of each cell suspension and 0.4% Trypan Blue
solution. Approximately 10µl of this solution was loaded onto a hemocytometer and
incubated for 2 minutes at room temperature. Viable cells remained unstained and
translucent in appearance, whereas non-viable cells were stained blue. All unstained and
blue cells within a 1 x 1 mm square were manually counted in triplicate experiments. Data
were plugged into Excel to determine % viability and analyzed using Prism.
6.2.3 Live cell imaging and analysis of granule
For granule formation, morphology and count assays, live cell imaging was
conducted on transiently transfected S2R+ cells. Cells were plated on poly-d lysine coated
imaging dishes 72 hours post-transfection and imaged within 2 hours of plating. In all
experiments, images were obtained using an Olympus FV3000 confocal laser scanning
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microscope and cells were visualized with a 100x (NA 1.4) objective digitally zoomed to
2.95x for best resolution.
To count the number of transfected cells able to form granules, approximately 100
cells were manually identified at the microscope. The total number of cells that formed
granules out of all EGFP-expressing cells were counted. Cells were scanned through in Z
to make sure that granules in any plane were identified. The number of granule-forming
cells was divided by total number of transfected cells in three separate experiments.
To compare the propensity of the different mutants to form spherical granules,
approximately 100 granule-forming transfected cells were identified at the microscope.
The number of cells forming spherical and amorphic (non-spherical) granules were
counted. In most cases, cells that formed amorphous granules also contained spherical
granules-- cells that formed any number of amorphous granules were categorized as
amorphic.
Finally, to count granules formed by each FMRP-mutant, 15 cells were analyzed in
a single experiment. The z-plane where the nucleus took up the largest cell area was
examined. Punctate areas of fluorescence intensity above background were considered to
be granules and counted using ImageJ’s cell counter plugin. For each image, both cell
diameter (through the longest axis in the same z-plane) and granule number were collected.
From this, the number of granules per cell area (μm2) was plotted.
Data from each of these experiments was entered into Excel for initial analysis.
These data were then entered into Prism for statistical analysis.
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6.2.4 Fluorescence Recovery After Photobleaching
For FRAP experiments, 17-21 EGFP positive granules were viewed with a 100x
(NA 1.4) objective digitally zoomed to 2.95x and photobleached with the lowest laser
intensity necessary to completely bleach ROI, ranging from 2.44-10% 488nm laser power
for 500-1,000 milliseconds. Two pre-FRAP images were collected and images were
captured every 1.0878 seconds pre and post bleaching for a total of 200 frames.
To set up the FRAP analysis, images were initially processed in ImageJ2/FIJI
(Rueden et al., 2017; Schindelin et al., 2012). Data were analyzed essentially as described
in (Cheney et al., 2017). A ROI was manually traced in each FRAP movie for 1) the
bleached granule, 2) an unbleached granule, and 3) diffuse cytoplasmic staining for
background. To ensure that fluorescence was accurately measured, ROI was moved
throughout the movie if/when granules moved in x/y out of the initially set ROI to maintain
consistency. From these movies, the mean fluorescent intensity was obtained for each
frame and plugged into an excel sheet. Using these data, the following was calculated: 1)
Photobleach Correction Value (PCV), in which the initial pre-bleach unbleached granule
average fluorescence intensity was divided by each subsequent unbleached granule average
intensity, 2) Corrected Average Intensity (CAI), where the bleached granules mean
intensity was multiplied by the PCV, 3) Background Corrected Fluorescence Intensity
(BCFI), where the CAI was subtracted by the average intensity of the background ROI,
and 4) the Final Corrected Value (FCV) which was calculated by dividing each BCFI by
the initial BCFI value and multiplying by 100 to get a normalized fluorescence intensity
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profile. The FCV’s from each movie were then plugged into a nonlinear fit in Prism to
calculate the fluorescence recovery curve, mobile fraction, and half-life.
For the IDR FRAP analysis, WT-FMRP Relative Fluorescence was adjusted posthoc. For some unknown reason, WT granules were bleached to an average fluorescence
intensity of -20 following photobleaching, which caused a shift in the recovery curve. As
this did not occur in WT in our FXS-causing point mutant WT, we did not believe this was
the true representation of these data. To adjust for this, each data point was increased by
20 to account for this deviation.
6.2.5 Immunocytochemistry, arsenite and 1,6-hexanediol treatments
The following immunocytochemistry procedure was followed for all S2R+/S2 cell
imaging, unless indicated otherwise. Cells were plated, immunostained and imaged on 35
mm glass bottom dishes with 10mm #1 cover glass (Cellvis; D35-10-1-N). After allowing
cells to settle on imaging dishes for at least 20 minutes, they were fixed with 4% PFA for
10 minutes followed by a 5-minute incubation with ice cold methanol at -20°C. Cells were
washed three times for 5 minutes in 1xPBS (pH 7.4), permeabilized in 1xPBST (pH 7.4)
for 10 minutes, and then blocked in 1xPBST with 2% BSA (w/v; Sigma-Aldrich, A9647)
and 5% normal goat serum (v/v; Sigma-Aldrich, S26-M) for 30 minutes. Cells were
incubated with primary antibodies overnight at 4°C, washed in 1xPBS, and then incubated
for 1 hour in secondary antibodies at room temperature. Cells were washed with 1xPBS
and then mounted in DAPI-Fluoromount-G Clear Mounting Media and sealed by adhering
a #1 coverslip to the dish.
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For FXS-causing point mutants/HPat colocalization experiments, immunostaining
was conducted on cells transfected with pAc5.1B:EGFP-FMRP and FXS-causing point
mutants. For this assay, rabbit anti-HPat (1:1,500) primary and goat anti-rabbit Alexa-567
(1:500) secondary antibodies were used.
To induce stress, cells were co-transfected with pAc5.1B:EGFP-FMRP mutants
and pAc5.1B-Rasputin(Gly4Ser)3mCherry. At 72 hours post transfection, cells were treated
with 0.5mM sodium meta-arsenite in M3+BPYE media for 45 minutes. For colocalization
analysis, cells were immediately fixed in 4% PFA for 10 minutes, incubated with ice cold
methanol at -20°C for 5 minutes and then washed 3 times for 5 minutes in 1xPBS (pH 7.4).
Preparations were then mounted in DAPI-Fluoromount-G Clear Mounting Media
(Southern Biotech).
For analysis of granules with 1,6-hexanediol transfected cells were co-transfected
with pAc5.1:EGFP-FMRP mutants and pAc5.1-Rasputin(Gly4Ser)3mCherry. Non-stressed
cells were imaged via CLSM on either fresh cell culture media or 10% 1,6-hexanediol
(w/v) in media. Cells were imaged within 20 minutes of the addition of hexanediol, as cells
start to bleb and stress granules begin to form after long exposure times (Wheeler et al.,
2016). Stressed cells were treated with 0.5 mM sodium arsenite for 45 minutes before the
addition of fresh 0.5 mM arsenite, or 0.5 mM arsenite + 10% 1,6-hexanediol. In all
conditions, approximately 100 live transfected cells were analyzed for the presence of
FMRP or Rin granules, in triplicate. Data from each of these experiments was entered into
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Excel for initial analysis. These data were then entered into Prism where we performed
statistical analysis and created graphs.
6.2.6 Colocalization analysis
To determine the degree to which FMRP mutants colocalized with SG or P-body
components, 12-13 images were analyzed in ImageJ/FIJI using the Just Another
Colocalisation Plugin, JACoP (Bolte and Cordelières, 2006). In all cases, images were
cropped to the smallest area possible to eliminate colocalization events outside of the cell
of interest and images for FMRP/HPat colocalization were background subtracted to a
rolling ball radius of 50 pixels to account for the higher degree of HPat background
staining. In JACoP, Pearson’s coefficient analysis was performed between the FMRP and
SG or P-body channels which were recorded in Excel and analyzed in Prism.
6.2.7 Western blotting
Western blots were generally carried out as follows. Samples were boiled at 95°C
for 10 minutes, chilled on ice for 5 minutes and sonicated for three one second pulses, with
one second pauses in between at 50 mW on ice. Samples were chilled on ice for 5 minutes
before clarification at 15,000X G for 15 minutes at 4°C. Supernatants were carefully
transferred to a fresh microfuge tube on ice, and then 15-25 μL of sample was added per
well in a 4-20% Mini-PROTEAN TGX Precast Protein Gel (Bio-Rad, #4561094). Gels
were run at 250V for 35 minutes or until adequate separation was achieved. Prior to protein
transfer, the SDS-PAGE gel and nitrocellulose membrane were equilibrated in 1x transfer
buffer for 10 minutes with agitation. Gel transfer to nitrocellulose membrane was run at
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120V for 45 minutes on a stir plate with an ice pack to keep the solution cool. The
nitrocellulose membrane was then incubated in blocking solution (5% non-fat milk in 1X
TBST pH 7.4) for 30 minutes at room temperature with agitation. Primary antibodies were
diluted in blocking solution (indicated below) and incubated with membrane for either 2
hours at room temperature or overnight at 4°C with agitation. Membranes were washed 5
times in 1X TBST with agitation. Secondary antibodies were diluted in blocking solution
and incubated with membrane for 45 minutes to 1 hour at room temperature with agitation.
Membranes were washed in TBST for 5 minutes 3 times with agitation. Approximately 1
mL of Thermo Scientific SuperSignal West Dura Chemiluminescent Substrate (Thermo
Scientific; 34075) was incubated with membrane before imaging on a FluorChem R
(ProteinSimple).
For westerns conducted on EGFP-FMRP mutant ectopic expression assays in S2R+
cells, transfected cells were harvested at three days post-transection from a 6-well plate.
Cells were scraped and resuspended by pipetting up and down and 1.5 mL of cells were
spun down at 1,000x G for 5 minutes at 4°C. Cells were then resuspended in 400 μL of 2x
Laemmli sample buffer + -mercaptoethanol on ice.
For westerns conducted on C380, cha-Gal80/+ ; ; UAS:EGFP-FMRP, FMR1∆50M/+
larvae ectopically expressing the FXS-causing point mutants, 5 CNS’s were diluted in
100µL of 2x Laemmli sample buffer +

-mercaptoethanol on ice. CNS’s were

homogenized in a 1.6 mL microcentrifuge tube for 30 seconds on ice using a hand-held
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homogenizer. Homogenate was incubated on ice for 3 minutes, and then processed as
indicated above.
For both of these assays, the primary antibodies used were mouse anti-dFMR1
(1:3,000), rabbit anti-EGFP (1:2,000), and mouse anti-ɑ-tubulin (1:1,000). Secondary
antibodies used were horse anti-mouse HRP or goat anti-rabbit HRP which were diluted
1:1,000 in block.
6.2.8 Primary motor neuron imaging and neurite transport analysis
Primary motor neurons were cultured from flies as indicated in section 6.1.3. At 35 days post-harvest, live primary motor neurons were imaged using an Olympus FV3000
scanning confocal microscope with a 100x (NA 1.4) objective. For soma imaging, images
were digitally zoomed to 2.95x for optimal resolution and a z-stack was obtained with
0.39µm slices through the entire soma. Images were presented as Z-projections which were
made using Fiji/ImageJ.
For neurite transport movies, live cells were imaged with the 100x objective
digitally zoomed to 1.79x so most branching neurites were imaged. Movies were collected
containing four 0.39µm z-slices, over 100 frames (8:04 minutes). Movies were then
analyzed using the Kymolyzer plugin in FIJI/ImageJ from which granule velocities and
directionality were obtained, using a lower speed limit set to the pixel size, 0.138µm. (Basu
et al., 2020).
To calculate the average number of neuritic granules in primary motor neurons, the
max-intensity Z-projection of the first time point imaged was used (Frame 1). The Cell
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Counter plugin was used to manually count the number of granules within neurites for each
of the movies used for tracking neuritic granules. Additionally, the proportion of neuritic
granules 10µm or further from the cell body was determined from these images. The scale
of these images was globally set and a symmetrical circle was drawn tightly around each
cell using the Oval selection tool in ImageJ, containing as much of the cell as possible. The
diameter of each cell body was recorded in µm. The center of each circle was determined
and marked using the Pencil tool. From this point, a line was drawn to the center of each
granule within neurites and crude distance from the cell body was recorded in µm. The
distances recorded were subtracted by the radius for their respective cell body to obtain the
final distance used in analysis. Data were recorded in Excel and statistical analyses were
performed in Prism.
6.2.9 Single molecule FISH and FISH-quant image analysis
Primary motor neurons were cultured from flies driving expression of UASEGFP:FMRP, FMR∆50 under the control of the C380,cha-Gal80 driver as described in
section 6.1.3. Custom Stellaris® FISH Probes were designed against Drosophila
melanogaster fmrI, camkII, futsch, and chic by utilizing the Stellaris® FISH Probe Designer
(Biosearch

Technologies

Inc.,

Petaluma,

CA)

available

online

at

www.biosearchtech.com/stellarisdesigner. Primary motor neurons were hybridized with
the indicated Stellaris FISH Probe set labeled with either Quasar-570 or 670 (Biosearch
Technologies, Inc.) following the manufacturer’s instructions available online at
www.biosearchtech.com/stellarisprotocols. Essentially, at 3-4 days post culturing, cells
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growing on #1.5 cover glass were washed in 1X PBS (pH 7.4). Cells were then incubated
in fixation buffer (3.7% formaldehyde in 1X PBS) for 10 minutes at room temperature,
then washed twice in PBS. To permeabilize cells were immersed in 70% ethanol at 4°C for
at least 1 hour and up to a week. Ethanol was aspirated and cells were washed in Stellaris
Wash Buffer A for 5 minutes, then hybridized with the indicated probe(s) in a dark, humid
hybridization chamber at 37°C for 5-16 hours. Probes were used at a final molarity of
0.125µM in Stellaris Hybridization buffer. Hybridization buffer was aspirated and cells
were incubated with Wash Buffer A twice at 37°C for 30 minutes, then washed with
Stellaris Wash Buffer B for 5 minutes at room temperature. Buffer was aspirated and
Vectashield Mounting Medium was added to the #1.5 cover glass in the imaging dish and
a clean coverslip was placed on top and sealed with clear nail polish. Imaging dishes were
stored in the dark at -20°C for up to 2 days before imaging on an ONI Nanoimager S.
Approximately 15 cells were imaged per genotype using the widefield microscopy
application on the ONI Nanoimager S for imaging smFISH probes. In order to detect
smFISH probes, cells were exposed to 7% 570- or 640-laser power for 1,500 milliseconds.
Z-projection was obtained with 0.2 µm slices through the entire cell. EGFP-FMRP was
imaged sequentially which allowed us to distinguish the soma and neurites from
background.
To analyze smFISH images, we used the FISH-Quant Matlab application to detect,
localize and quantify mRNA in primary motor neurons (Mueller et al., 2013). Motor
neuron soma and neurites were outlined individually, which allowed us to differentiate
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mRNAs residing within the soma and neurites. Data were compiled in Excel and statistical
analyses were performed in Prism.
6.2.10 Luciferase reporter assays
Transfections were performed in three biological replicates in 24-well plates. For a
single well, 0.025 µg of the firefly luciferase (FLuc) 3’ UTR mRNA reporter plasmid, 0.1
µg of the Renilla luciferase (RLuc) transfection control plasmid, and 0.25 µg of either the
empty λN vector or the λN: FMRP mutant vector was transfected. At three days post
transfection, cells were thoroughly scraped and resuspended and 75 µL of cells were added
in three technical replicates to a 96-well white, flat bottom polystyrene assay plate (Costar).
Following the Dual-Glo Luciferase Assay System kit protocol (Promega), an equal volume
of Dual-Glo Reagent and then Dual-Glo Stop & Glo Reagent were added to each well and
incubated for 15 minutes before measuring FLuc and RLuc luminescence,
respectively. Luminescence was measured using a Synergy™ HTX Multi-Mode
Microplate Reader (BioTek).
6.2.11 Larval NMJ immunohistochemistry and morphological analysis
Third instar larval body wall preps for NMJ analysis were dissected in ice cold
calcium-free Jan and Jan buffer (130 mM NaCl, 5 mM KCl, 36 mM sucrose, 5 mM HEPES
[pH 7.3], 4 mM MgCl2, and 0.5 mM EGTA) within 30 minutes on sylgard plates.
Dissection buffer was removed and preps were fixed in 4% PFA for 20 minutes, then
washed 3x 5 minutes in 1X PBS (pH 7.4) and permeabilized in 1X PBS (pH 7.4) + 0.1%
Triton X-100 for 10 minutes. Preps were blocked in 1X PBS with 2% BSA and 5% normal
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goat serum with shaking for 30 minutes. Block was removed and primary antibody (mouse
anti-DLG, 1:200) diluted in block was incubated overnight at 4°C. Preps were washed 6x
5 minutes in PBS and then incubated for 1 hour with secondary antibodies diluted in block
at room temperature (goat anti-mouse Alexa 488 or 567 at 1:500 & Dylight 649-conjugated
anti-HRP at 1:500). Preps were washed in 1xPBS and then mounted on slides in DAPIFluoromount-G Clear Mounting Media.
All imaging was done on an Olympus FV3000 scanning confocal microscope using
20X and 60X objectives to image the NMJ at muscles 6/7 in abdominal section 3 (N.A.
0.85 and 1.42, respectively). When shown, maximum Z projections were assembled from
0.4μm optical sections. All post-hoc image processing was done using Fiji in ImageJ2. For
morphological analysis of larval NMJs, between 10-17 images were examined per
experiment, in which 1s, 1b and axon terminals were manually counted at muscles 6 and 7
(m6/7) in abdominal segment 3 (A3) using the Cell Counter plugin in Fiji. To account for
muscle area differences between genotypes which effects NMJ size, synaptic bouton
numbers were normalized to muscle surface area (MSA). MSA was calculated by outlining
both m6/7 using the freehand selection tool in ImageJ2/Fiji and recording the calculated
muscle area. 1s and 1b bouton numbers were divided by the corresponding muscle area.
These data were then normalized to the C380-Gal4/+;; UAS-EGFP/+ overexpression
controls. Data were collected and calculations were conducted in Excel and statistical
analyses were performed in Prism.
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6.2.12 Quantification and statistical analysis
All data were initially recorded in Excel (Microsoft) and then graphed and analyzed
in Prism version 9.0.2 (GraphPad). Results were considered statistically significant if
p<0.05. Error bars throughout the study indicate mean ± SEM. n.s. = not significant, *
p<0.05, ** p<0.01, *** p<0.001, and **** p<0.0001. Outliers were identified and removed
using ROUT method in Prism, where necessary. Statistical tests and sample sizes for each
experiment are indicated within the corresponding figure legend and/or in methods section.
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Biolabs
New England
Biolabs

Q5 Site-Directed Mutagenesis kit
One-Taq Polymerase
Dual Glo Luciferase Assay System
Effectene Transfection kit

E0554S
M0480

Promega

E2920

Qiagen

301425

Experimental Models: Cell Lines
Drosophila
NIH Grant
Genomics
2P40OD01094
Resource Center
9

D. melanogaster: Schneider's 2 cells (S2R+)
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D. melanogaster: Schneider's 2 cells (S2)
Experimental Models: Organisms/Genotypes

Bloomington
Drosophila Stock
Center
Bloomington
D. melanogaster: C380-Gal4
Drosophila Stock
Center
Bloomington
1118
D. melanogaster: w ; UAS-FMR1
Drosophila Stock
Center
Bloomington
D. melanogaster: w1118;; FMR1Δ50M/TM6B,Tb+
Drosophila Stock
Center
Bloomington
Δ113M
+
D. melanogaster: w*;; FMR1
/TM6B,Tb
Drosophila Stock
Center
(Hartwig et al.,
D. melanogaster: C380-Gal4, cha-Gal80
2008)
Bloomington
D. melanogaster: w1118; wgSp-1/CyO, P{w+mC=2xTb1Drosophila Stock
RFP}CyO; MKRS/TM6B, Tb1
Center
D. melanogaster: BL Canton S

D. melanogaster: C380-Gal4;; Sb/ TM6B,Ser

This paper

D. melanogaster: pUAST-attB-EGFP

This paper

D. melanogaster: pUAST-attB-EGFP:FMRP

This paper

D. melanogaster: pUAST-attB-EGFP:FMRP:KH1*

This paper

D. melanogaster: pUAST-attB-EGFP:FMRP:KH2*

This paper

D. melanogaster: pUAST-attBEGFP:FMRP:KH1*KH2*

This paper

D. melanogaster: pUAST-attB-EGFP:ΔKH

This paper

+

Δ50M

D. melanogaster: w ; FMR1
, pUAST-attBEGFP/TM6BTb
D. melanogaster: w+; FMR1Δ50M, pUAST-attBEGFP:FMRP/TM6BTb
140
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BDSC:64349

BDSC:80580

BDSC:6931

BDSC:6928

BDSC:67403

BDSC: 76359

D. melanogaster: w+; FMR1Δ50M, pUAST-attBEGFP:FMRP:KH1*/TM6BTb
D. melanogaster: w+; FMR1Δ50M, pUAST-attBEGFP:FMRP:KH2*/TM6BTb
D. melanogaster: w+; FMR1Δ50M, pUAST-attBEGFP:FMRP:KH1*KH2*/TM6BTb
D. melanogaster: w+; FMR1Δ50M, pUAST-attBEGFP:ΔKH/TM6BTb
D. melanogaster: C380,cha-Gal80;;
TM6BTb/TM3BSb
D. melanogaster: C380,cha-Gal80;;
TM6BTb/FMR1Δ113M
D. melanogaster: C380-Gal4;; FMR1Δ113M/TM6BTb

This paper
This paper
This paper
This paper
This paper
This paper
This paper

Oligonucleotides
FMR1 deletion (PCR forward primer): 5'AAGGAAAAAAGCGGCCGCAAAGATATCGCG
AAAATCCCCCCAG-3'

(Zhang et al.,
2001)

FMR1 deletion (PCR reverse primer): 5'CGGGATCCGTTATGCTACGTGAATAAATC-3'

(Zhang et al.,
2001)

FMRP-pUAST (PCR amplification forward primer
with 5'-KpnI site):

This paper

FMRP-pUAST (PCR amplification forward primer
with 3'-EcoRI site):

This paper

KH1 SDM (Forward primer for mutagenesis of the
KH1 domain in dmFMRP [Gly269Glu]): 5'
CAAAATCAGCGAAGAGACCGAGG -3'

This paper

KH1 SDM (Reverse primer for mutagenesis of the
KH1 domain in dmFMRP [Gly269Glu]): 5'AATGTGCAGGACTTCTCC-3'

This paper

KH2 SDM (Forward primer for mutagenesis of the
KH2 domain in dmFMRP [Ile307Asn]): 5'GGGCGCATTAACCAGGAGATTG-3'

This paper

KH2 SDM (Reverse primer for mutagenesis of the
KH2 domain in dmFMRP [Ile307Asn]): 5'ATTCTTGCCAATCACCTTGC-3'

This paper
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DP-90 (FMRP PCR amplification forward primer
with 5'-HindIII site): 5'ACAAGCCAAGCTTTATGGAAGAT-3'
ES-51 (FMRP:∆IDR amplification reverse primer
with 3' EcoRI): 5'TACGGAATTCTTACTTCTCCTGACGCAACTGT
T-3'
ES-135 (EGFP amplification forward primer): 5'GGTACCAACATGGTGAGCAA-3'
ES-136 (EGFP amplification reverse primer with 3'XbaI site): 5'GTTCATCTAGACTACTTGTACAGCTCGTCCAT
GC-3'
ES-83 (KH1+2 amplification forward primer with 5'
HindIII site): 5'AAGCCAAGCTTTGGAAACTACGTTGAGGAGT
T-3'
ES-82 (KH1+2 amplification reverse primer with 3'
AscI site): 5'ATCTCGGCGCGCCGCGACAGATGATACTCCA
AC-3'
ES-60 (IDR amplification forward primer with 5'
HindIII site): 5'GTCAAAGCTTCGAGATTGATCAGCAGCTTC-3'
ES-53 (IDR amplification reverse primer with 3'
EcoRI site): 5'TACGGAATTCTTAGGACGTGCCATTGACCA-3'
DP-140 (FMRP KH0 deletion amplification reverse
primer with BamHI 5' site): 5'ATGACGGATCCCAGACGACCCAATTCACAGA
TT-3'
DP-141 (FMRP KH0 deletion amplification forward
primer with BamHI 3' site): 5'ATGACGGATCCTACGTTGAGGAGTTCCGTGT
G-3'
DP-142 (FMRP KH1+2 deletion amplification
reverse primer with BamHI site): 5'ATGACGGATCCCTCAACGTAGTTTCCACGGC3'
142

This paper

This paper
This paper

This paper

This paper

This paper

This paper

This paper

This paper

This paper

This paper

DP-143 (FMRP KH1+2 deletion amplification
forward primer with BamHI site): 5'ATGACGGATCCCTGGCGCATGTACCCTTTGT3'
DP-93 (FMRP amplification primer with EcoRI 3'
site): 5'-TCTGCAGAATTCTTAGGACGTG-3'
DP-91 (FMRP RGG deletion amplification reverse
primer with EcoRI site): 5'TGACGGATCCATCGTTGTAGCCACGCTGCT-3'
DP-92 (FMRP RGG deletion amplification primer
with EcoRI site): 5'TGACGGATCCCCGCCACGCAACGATCAGCA-3'
ES-139 (FMRP LIC amplification forward primer):
5'TACTTCCAATCCAATGCAGAAGATCTCCTCGT
GGAAGTTCGGC-3'
ES-140 (FMRP LIC amplification reverse primer): 5'TTATCCACTTCCAATGTTATTAGGACGTGCCA
TTGACCAGGCC-3'
DP-204 (mcherry amplification forward primer with
5' HindIII site): 5'AGTACAAGCTTATGGTGAGCAAGGGCGAGGA
G-3'
DP-205 (mcherry amplification reverse primer with 3'
BamHI site): 5'AGTACGGATCCTTACTTGTACAGCTCGTCCAT
GCCG-3'
DP-206 (Top oligonucleotide for cloning (Gly4Ser)3
linker upstream of mcherry, containing a 5' ApaI site,
and 3' HindIII site to clone directionally into pAc5.1):
5'CGGTGGAGGAGGCTCTGGTGGAGGCGGTAGC
GGAGGCGGAGGGTCGA-3'
DP-207 (Bottom oligonucleotide for cloning
(Gly4Ser)3 linker upstream of mcherry, containing
ApaI and HindIII sites): 5'AGCTTCGACCCTCCGCCTCCGCTACCGCCTCC
ACCAGAGCCTCCTCCACCGGGCC-3'
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This paper

This paper

This paper

This paper

This paper

This paper

This paper

This paper

This paper

ES-170 (Rasputin RT-PCR primer with 5' KpnI site):
5'-TGACATGGTCATGGATGCGACCCA-3'
ES-171 (Rasputin RT-PCR primer with in-frame stop
codon and 3'-EcoRI site): 5'ATACGAATTCGCGACGTCCGTAGTTGCCA-3'
CaMKIIUTRFwdGA (CaMKII 3'UTR Gibson
assembly primer for cloning into FLuc backbone
vector cut with EcoRI and XhoI): 5'CGGAAAGTCCAAATTGTAATGGGCATTAATC
AATGGAATATAAAC-3'
CaMKIIUTRRvsGA (CaMKII 3'UTR Gibson
assembly primer for cloning into FLuc backbone
vector cut with EcoRI and XhoI): 5'CTTACCTTCGAATGGGTGACAAAATTGCATTA
TGCTTTGAATTC-3'
FMR1Fwd (Forward restriction primer for cloning
FMR1's 3'UTR containing the 5' EcoRI site): 5'TACTGAATTCAGGAGCAACAGCTCACAG-3'
FMR1Rvs (Reverse restriction primer for cloning
FMR1's 3'UTR containing the 3' XhoI site): 5'ATACCTCGAGGCTTGATGGTTTGTGTTTTG-3'

This paper

This paper

This paper

This paper

This paper

This paper

Recombinant DNA
Plasmid: pUAST-attB
DGRC
Plasmid: pUAST-attB-EGFP

This paper

Plasmid: pUAST-attB-EGFP:FMRP

This paper

Plasmid: pUAST-attB-EGFP:FMRP:KH1*

This paper

Plasmid: pUAST-attB-EGFP:FMRP:KH2*

This paper

Plasmid: pUAST-attB-EGFP:FMRP:KH1*KH2*

This paper

Plasmid: pAc5.1B-EGFP

Addgene

Plasmid: pAc5.1-EGFP:FMRP

This paper

Plasmid: pAc5.1-EGFP:FMRP:KH1*

This paper

Plasmid: pAc5.1-EGFP:FMRP:KH2*

This paper

Plasmid: pAc5.1-EGFP:FMRP:KH1*KH2*

This paper

Plasmid: pAc5.1-EGFP:FMRP:∆KH

This paper
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Plasmid: pAc5.1-EGFP:FMRP:∆IDR

This paper

Plasmid: pAc5.1-EGFP:FMRP:IDR

This paper

Plasmid: pAc5.1-EGFP:FMRP:KH+IDR

This paper

Plasmid: pAc5.1-Rasputin-(Gly4Ser)3-mCherry

This paper

Plasmid: pAc5.1B-λN:HA

Addgene

Plasmid: pAc5.1-λN:HA:FMRP

This paper

Plasmid: pAc5.1-λN:HA:FMRP:KH1*

This paper

Plasmid: pAc5.1-λN:HA:FMRP:KH2*

This paper

Plasmid: pAc5.1-λN:HA:FMRP:KH1*KH2*

This paper

Plasmid: pAc5.1B

Invitrogen

Plasmid: pAc5.1-FMRP

This paper

Plasmid: pAc5.1-FMRP:KH1*

This paper

Plasmid: pAc5.1-FMRP:KH2*

This paper

Plasmid: pAc5.1-FMRP:KH1*KH2*

This paper
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APPENDIX 2: smFISH PROBE OLIGONUCLEOTIDES
Sequence Name

Sequence

Three Modification

camkii-1_1

GAAAAACGCGTACAGGCTGC

Quasar 670

camkii-1_2

CCAACTCTTCTTTGATGTCG

Quasar 670

camkii-1_3

GCAGCAAATTCAAAGCCAGT

Quasar 670

camkii-1_4

CACTATGTTGGGATGGTGTA

Quasar 670

camkii-1_5

CTCCTGTATACTGTCATGTA

Quasar 670

camkii-1_6

AATGTGATGCATCAGCTTCT

Quasar 670

camkii-1_7

CATTTTGGTGGCAGTGATTG

Quasar 670

camkii-1_8

ATTCTCTGGTTTCAGATCTC

Quasar 670

camkii-1_9

AGACCAAAGTCAGCGAGTTT

Quasar 670

camkii-1_10

CTGATGATCGCCTTGAACTT

Quasar 670

camkii-1_11

CTCCTTTTTCAATACCTCAG

Quasar 670

camkii-1_12

AAGAATAACTCCACATGCCC

Quasar 670

camkii-1_13

TGCTGATCTTCATCCCAAAA

Quasar 670

camkii-1_14

ACGGATAATCATAAGCTCCC

Quasar 670

camkii-1_15

TTTAGCTTCTGGAGTAACCG

Quasar 670

camkii-1_16

GATGTTTTAAAGCCTCAGCT

Quasar 670

camkii-1_17

CACACGTTCGCGTTGACAAA

Quasar 670

camkii-1_18

CTTGAGACAGTCTACGGTTT

Quasar 670

camkii-1_19

CGCCAACATTGTCGTAAGTA

Quasar 670

camkii-1_20

GTTATCATACTTCTGCTCGA

Quasar 670

camkii-1_21

GTTGATTCTTTGACCTGTGA

Quasar 670

camkii-1_22

CGTCTTCAAGAGTAGTGCTA

Quasar 670

camkii-1_23

GCCACTGTTAATTGCTTCAA

Quasar 670

camkii-1_24

CAAAGGCAGTTAGATGCGGA

Quasar 670

camkii-1_25

ATTCCTTCTACAAGGTTACC

Quasar 670

camkii-1_26

GCTTTGCAGTTTTTACCAAG

Quasar 670

camkii-1_27

CTTCACCAAGTAAGTGCACA

Quasar 670

camkii-1_28

GTCTCACATAGGCAATGCAA

Quasar 670
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camkii-1_29

CATTCTGCCATTTGTTATCG

Quasar 670

camkii-1_30

CTTATTTTGGCAGATGCACT

Quasar 670

147

